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Abstract
The differential diagnosis of Ménière's disease (MD) and vestibular migraine (VM) is 
difficult, due to a reliance on symptom-based diagnosis despite frequently overlapping 
symptoms. A systematic review was conducted of studies investigating diagnostic features in 
patients with MD and VM that may assist differential diagnosis. A scoping review was also 
conducted of tests with high sensitivity and specificity for MD or VM. The systematic review 
identified that caloric testing was 54.6% sensitive and 78.9% specific for separating MD from 
VM (with MD as a positive result). Other potentially useful tests were identified, but more 
studies are needed. The scoping review identified several tests that not have yet been
evaluated for the differential diagnosis of MD and VM (primarily gadolinium magnetric 
resonance imaging and tone-burst electrocochleography). Several other promising tests were 
identified, but have not been sufficiently tested with appropriate control groups.
Keywords: Ménière's disease, vestibular migraine, diagnostic accuracy, systematic review, 
differential diagnosis
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ABR – auditory brainstem response
AP – action potential
CHAMP – cochlear hydrops analysis masking procedure
CI – confidence interval
cVEMP – cervical vestibular evoked  myogenic potential
dB HL – decibels hearing level
ECoG - electrocochleography
EVestG - electrovestibulography
FAR – frequency amplitude ratio
fMRI – functional magnetic resonance imgaing
GRADE - grading of recommendations assessment, development, and evaluation
ICHD-3 - International classification of headache disorders 3rd edition
HSN – head shaking nystagmus
LMPT – linear motion perceptual threshold
MD - Ménière's disease
MRI – magnetic resonance imaging
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NA – noradrenaline / norepinephrine
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PIVC - parieto-insular vestibular cortex
PRISMA - preferred reporting items for systematic reviews and meta-analyses
PTA – pure-tone audiometry
QUADAS - quality assessment of diagnostic accuracy studies
SCC – semi-circular canal
SHA – sinusoidal harmonic acceleration
SP – summating potential
STARD - standards for reporting of diagnostic accuracy
SVT – step velocity test
TB – tone burst
VCR – vestibulo-collic reflex
vHIT – video head impulse test
VIN – vibration-induced nystagmus
VM – vestibular migraine
VOR – vestibulo-ocular reflex
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Glossary
Dizziness – Sensation of disturbed or impaired spatial orientation without false sense of 
distorted motion. Distinct from vertigo (Bisdorff, Von Brevern, Lempert, Newman-Toker, & 
others, 2009).
Ictal – A physiological state or event.
Interictal – The period between physiological events.
Nystagmus – Non-voluntary rhythmic oscillation of the eyes. Nystagmus usually has a fast 
and slow component. The direction of nystagmus is defined by the fast component (Baloh, 
Honrubia, & Kerber, 2010)
Oscillopsia – False sensation that the visual surround is oscillating (Bisdorff et al., 2009).
Saccade – A rapid movement of the eye between fixation points.
Unsteadiness – The feeling of being unstable while seated, standing, or walking (Bisdorff et 
al., 2009).
Vertigo – The sensation of self-motion when no self-motion is occurring or the distorted self-
motion during otherwise normal head movement (Bisdorff et al., 2009).
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1.0 Introduction
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The differential diagnosis of Ménière's disease (MD) and vestibular migraine (VM) is 
difficult, due to a reliance on symptom-based diagnosis despite frequently overlapping 
symptoms. The intent of this thesis is to conduct a systematic review of the differential 
diagnosis of MD and VM and a scoping review of accurate diagnostic tests for MD or VM. 
The first section of the introduction will outline the vestibular system. The next section will 
summarise MD and VM and the current issues surrounding their differential diagnosis. The 
third section will briefly summarise the current theory and methodology behind diagnostic 
accuracy. The fourth section will briefly overview systematic review methodology. The final 
section of the introduction will summarise the aims of the present study.
1.1 The Human Vestibular System
The peripheral vestibular system is contained within the bony labyrinth in the inner 
ear (Figure 1). The bony labyrinth is filled with perilymph (having a similar composition to 
cerebrospinal fluid); (Wangemann & Schacht, 1996). The bony labyrinth includes three semi-
circular canals (SCCs), the vestibule and the cochlea. Inside the bony labyrinth is the 
membranous labyrinth. The membranous labyrinth is filled with endolymph (having a similar 
composition to intracellular fluid); (Wangemann & Schacht, 1996; Hain & Helminski, 2014). 
Primary afferent neurons from the utricle, anterior saccule, horizontal and superior SCCs
project along the superior vestibular nerve, while primary afferent neurons from the 
remaining saccule and, the horizontal SCC project along the inferior vestibular nerve 
(McRackan & Brackmann, 2015).
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Figure 1. The membranous labyrinth is located within the cavities of the bony labyrinth. The 
cochlear duct is shown in deep blue, and the remainder of the membranous labyrinth is shown 
in a light green color. (Reproduced with permission from Siegel, Sapru, & Siegel, 2014).
The superior and inferior vestibular nerves then enter the brainstem at the junction of 
the pons and medulla, before projecting to the vestibular nuclei (in the brainstem) and the 
cerebellum. The vestibular nuclei then project to secondary vestibular afferent neurons
(McRackan & Brackmann, 2015). The central vestibular system coordinates with the visual 
and proprioceptive senses to provide stability to the eyes through the vestibulo-ocular reflex 
(VOR), stability to the head and neck via the vestibulo-collic reflex (VCR), and body posture 
via the vestibulo-spinal reflex (VSR); (Mudduwa, Kara, Whelan, & Banerjee, 2010).
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1.1.1 Otolith Organs
The otolith organs are located within the vestibule. There are two otolith organs, the 
utricle and the saccule. The utricle is most sensitive to horizontal linear acceleration, whereas 
the saccule is most sensitive to sagittal linear acceleration. The otoliths contain a sensory 
epithelium called the macula. The striola is a region that runs along the centre of the macula, 
and is surrounded by hair cells. Hair cells in the saccule orient away from the striola, whereas 
hair cells in the utricle orient towards the striola (Figure 2). 
There are two types of vestibular hair cells. Type I hair cells typically have bouton 
endings and are primarily located away from the striola. Type II hair cells have calyx endings 
and are mainly located close to the striola. Hair cells are embedded in the otolithic 
membrane, a gelatinous structure containing calcium carbonite crystals (otoconia). Due to 
inertia, head movement will result in an opposite movement of the otolithic membrane, and 
therefore hair cells. This causes a change in the firing rate of hair cells in the otoliths 
(McRackan & Brackmann, 2015). 
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Figure 2. The otilith organs. a.) Anatomy of the macule b.) Mechanism of hair cell activation 
c.) Orientation of the utricle and saccule. (Reproduced with permission from Baloh et al., 
2010).
Hair cells in the otoliths project to primary vestibular afferent neurons. Vestibular 
primary afferent neurons are categorised by their interspike interval. Regular afferent neurons
primarily connect to extrastriolar type II hair cells, whereas irregular afferent neurons
primarily connect to striolar type I hair cells (McRackan & Brackmann, 2015). Regular 
afferent neurons respond tonically to macula displacement/head position, whereas irregular 
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afferent neurons respond phasic-tonically to velocity of the macula displacement (Leigh & 
Zee, 2015). Because of this regular afferents give information regarding head position, while 
irregular afferents detect sudden movements of the head.
1.1.2 Semicircular Canals (SCCs)
Each labyrinth contains three SCCs, resembling rings, which terminate in the utricle.
The horizontal SCCs are positioned 30o from the horizontal plane, while the anterior and 
posterior SCCs are positioned 45o from the sagittal plane (Figure 3). Each SCC has a dilated 
compartment called the ampula. The ampula contains the crista ampularis, an assortment of 
hair cells. The stereocilia and kinocilia of the hair cells are embedded in a gelatinous fluid-
filled compartment called the cupula (McRackan & Brackmann, 2015). 
DIFFERENTIAL DIAGNOSIS OF MD AND VM 17
Figure 3.The semicircular canals a.) Anatomy, b.) Mechanism of hair cell activation, and c.) 
Orientation of the semicircular canals. AC: anterior canal, PC: posterior canal, HC: horizontal 
canal (Reproduced with permission from Baloh et al., 2010).
Angular acceleration results in movement of the endolymph in the SCCs, which in 
turn moves the cupula and therefore the hair cells. Ampullopetal movement of endolymph 
(flow from the utricle to the ampule) is excitatory (in the direction of the kinocilium) in the 
horizontal SCC and inhibitory (away from the kinocilium) in the anterior and posterior SCCs.
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The opposite is true of ampullofugal endolymph movement (flow from the ampule towards 
the utricle); (McRackan & Brackmann, 2015).
1.1.3 Central Vestibular System
Figure 4 shows a simplified diagram of central vestibular connections. The vestibular 
nucleus is located in the medulla of the brainstem. The vestibular nucleus receives inputs 
from the visual, somatosensory, autonomic nervous systems, cerebellum, and both the 
contralateral and ipsilateral peripheral vestibular systems (McRackan & Brackmann, 2015).
From the vestibular nucleus, there are believed to be multiple ascending tracts. Several tracts 
have been implicated based on animal studies. These include the medial longitudinal 
fasciculi, the crossed and uncrossed ascending tract of Dieters, the crossed ventral tegmental 
tract, and the brachium conjuctivum. Projections are sent both ipsilaterally and contralaterally 
to the midbrain tegmentum, thalamus, and cortex (Dieterich & Brandt, 2015).
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Figure 4. Simplified pathways of the central vestibular system. Boxes with full lines are part 
of the central vestibular system.
The thalamus acts to process vestibular information and as a relay to and between the 
various cortical regions responsible for vestibular processing. The primary cortical region for 
vestibular processing is believed to be the parieto-insular vestibular cortex (PIVC). While the 
exact location of the PIVC is not known in humans, functional magnetic resonance imaging 
(fMRI) studies have indicated that it may be located at the posterior insula and tempero-
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other cortical regions that are involved in vestibular processing in humans. These regions 
include the superior temporal gyrus, inferior parietal lobule, somatosensory cortex, 
precuneus, cingulate gyrus, motor cortex, frontal eye field, and the hippocampus (Lopez & 
Blanke, 2011). Thalamic and cortical regions mediate the perception of vestibular inputs, 
while the brainstem mediates sensorimotor reflexes (VOR, VCR, and VSR); (Marianne 
Dieterich & Brandt, 2015).
1.2 Ménière's disease and Vestibular Migraine
This section will summarise the current understanding of symptomology, 
pathophysiology, and differential diagnosis of MD and VM.
1.2.1 Ménière's Disease
Ménière's Disease (MD) is characterised by repeated vestibular episodes, fluctuating 
hearing loss, aural fullness and tinnitus (Lopez-Escamez, Carey, Chung, Goebel, Magnusson, 
Mandalà, Newman-Toker, Strupp, Suzuki, Trabalzini, & others, 2015). The diagnosis of MD 
primarily relies on case history. Pure-tone audiometry (PTA) is also used to confirm hearing 
loss in MD (Gode et al., 2012). In most cases symptoms present unilaterally. However studies 
indicate that anywhere from 2 to 47% of patients with MD experience bilateral symptoms
(Huppert, Strupp, & Brandt, 2010). The reported prevalence of MD varies from 3.5 to 513 
per 100,000 (Wladislavosky-Waserman, Facer, Mokri, & Kurland, 1984; Alexander & 
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Harris, 2010) and accounts for approximately 8.3 to 10.1% of patients in dizziness clinics 
(Brandt & Strupp, 2006; Bunasuwan, Bunbanjerdsuk, & Nilsuwan, 2011).
Table 1. Current Clinical Definition of Definite MD (Lopez-Escamez, Carey, Chung, 
Goebel, Magnusson, Mandalà, Newman-Toker, Strupp, Suzuki, Trabalzini, & others, 2015).
A. Two or more spontaneous episodes of vertigo, each lasting 20 minutes to 12 hours. 
B. Audiometrically documented low to medium frequency sensorineural hearing loss in 
one ear, defining the affected ear on at least one occasion before, during or after one 
of the episodes of vertigo. 
C. Fluctuating aural symptoms (hearing, tinnitus or fullness) in the affected ear. 
D. Not better accounted for by another vestibular diagnosis.
Vestibular symptoms in MD are defined as disabling vertigo which is spontaneous or 
occurs during normal head movements. While not important for diagnosis, dizziness and 
unsteadiness are also frequently reported in patients with MD (Lopez-Escamez, Carey, 
Chung, Goebel, Magnusson, Mandalà, Newman-Toker, Strupp, Suzuki, Trabalzini, & others, 
2015). The course of hearing loss is also variable in MD. Most patients with MD show a 
progressive, sometimes fluctuating, hearing loss in the first 10 years of the condition. Hearing 
loss typically stabilises at an average level of 50-60 decibels hearing level (dB HL). The 
configuration of the audiogram is most commonly a flat configuration, but can also be can be 
rising, sloping, or peaked (Huppert et al., 2010).
Tinnitus in MD is most commonly unilateral (77%; Havia, Kentala, & Pyykkö, 2002). 
The tinnitus is commonly low in pitch, but its prevalence is reasonably evenly spread across 
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low, mid and high pitches (Herraiz, Tapia, & Plaza, 2006; Zagólski & Stręk, 2014; Zhang, 
Liu, Wang, Jia, & Gu, 2016), with an average perceived pitch at 3700 Hz (Zagólski & Stręk, 
2014). The perception of the tinnitus in MD is commonly described by patients as roaring, 
buzzing, ringing, or whistling (Vernon, Johnson, & Schleuning, 1980; Herraiz et al., 2006).
MD is a variable condition, particularly in its early stages. Only 38-40% of patients 
present with all symptoms necessary for a diagnosis, and symptoms can occur in any order
(Havia et al., 2002; Belinchon, Perez-garrigues, & Tenias, 2012; Pyykkö, Nakashima, 
Yoshida, Zou, & Naganawa, 2013). It may take several years for all symptoms to precipitate. 
Because of this, diagnosis can be difficult in the early stages of MD. It frequently takes years 
to reach an official diagnosis of MD (Belinchon et al., 2012; Pyykkö et al., 2013; Hietikko, 
Sorri, Männikkö, & Kotimäki, 2014).
Results from traditional bedside and oculomotor vestibular tests are also highly 
variable in MD (Table 2.). During the acute phase, 100% of patients present with 
spontaneous nystagmus. Spontaneous nystagmus occurs in the horizontal plane, towards or 
away from the affected ear (Meissner, 1981;McClure, Copp, & Lycett, 1981; Proctor, 2000;
Maire & van Melle, 2008; Marques & Perez-Fernandez, 2012; Hirai et al., 2017). The 
direction of nystagmus can also reverse (Meissner, 1981; Bance, Mai, Tomlinson, & Rutka, 
1991). Torsional nystagmus has also been reported in MD (Bance et al., 1991).
However patients with MD are typically seen in the interictal period. This is largely
due to the disabling nature of the attacks:- patients cannot typically visit a clinic until the 
attack is over (Hirai et al., 2017). One study found that 80% of patients with MD have at least
one abnormal finding in the interictal period (Shin, Kim, & Park, 2013). While abnormalities 
are common in these tests, no individual measure is highly sensitive, limiting their usefulness
in the diagnosis of MD.
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One finding, that has been repeatedly noted, is that caloric hypofunction is common in 
MD and increases in the early stages of MD (Huppert et al., 2010). This finding is rather 
unusual because the caloric test has historically been believed to test the horizontal SCC, and 
patients with MD tend to have a normal video head impulse test (vHIT) measures for the
horizontal SCC (Rambold, 2014; Zulueta-Santos, Lujan, Manrique-Huarte, & Perez-
Fernandez, 2014; McGarvie, Curthoys, MacDougall, & Halmagyi, 2015). It has been 
suggested that abnormal caloric results in MD may be due to endolymphatic hydrops of the 
horizontal semicircular canal (McGarvie et al., 2015).
Table 2. Results of bedside and oculomotor vestibular tests in MD during the interictal 
period. * = results of tests during ictal period.
Test







(Mateijsen et al., 2001; Chen & Young, 
2006; Marques & Perez-Fernandez, 2012;
Faralli, Lapenna, Mandalà, Trabalzini, & 
Ricci, 2014*; Zulueta-Santos et al., 2014;
Maire & van Melle, 2008*; Kumagami, 
Sainoo, Fujiyama, & Baba, 2009*; Faralli et 
al., 2014)*
Spontaneous + Gaze 
+ Static Positional 
Nystagmus




(Ohki, Matsuzaki, Sugasawa, & Murofushi, 
2002; Neff et al., 2012; Marques & Perez-





(Neff et al., 2012; Shin et al., 2013; Faralli et 
al., 2014;  Marques & Perez-Fernandez, 
2012)
Random saccade test 2.5 (3.5; 0-5)
(Somefun, Giwa, Bamgboye, Okeke-
Igbokwe, & Azeez, 2010; Neff et al., 2012)
Saccadic pursuit 5 (Neff et al., 2012)
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Table 2 continued. Results of bedside and oculomotor vestibular tests in MD during the 
interictal period. * = results of tests during ictal period.






(Kingma, Meulenbroeks, & De Jong, 2000); 
Mateijsen et al., 2001; Park, Migliaccio, 
Della Santina, Minor, & Carey, 2005; Chen 
& Young, 2006; Kumagami et al., 2009; 
Somefun et al., 2010; Gode et al., 2012 Shin 
et al., 2013; Blödow et al., 2014; Faralli et 
al., 2014; Sharon & Hullar, 2014; Marques 
& Perez-Fernandez, 2012; Satar, Karahatay, 
Sen, Cekin, & Birkent, 2008; McGarvie et 
al., 2015; Palomar-Asenjo, Boleas-Aguirre, 
Sánchez-Ferrándiz, & Perez Fernandez, 





(Mateijsen et al., 2001; Palomar-Asenjo et 
al., 2006; Neff et al., 2012)
vHIT 37.2 (29.4; 8-66.7)
(Blödow et al., 2014; Rambold, 2014; 






(Kingma et al., 2000; Palomar-Asenjo et al., 
2006; Park, Chen, & Westhofen, 2009)
Rotatory Chair (Step 
velocity test)






(Kumagami et al., 2009*; Faralli et al., 
2014)*
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1.2.2 Pathophysiology of Ménière's Disease
Hallpike and Cairns (1938) noted a dilation of the endolymphatic space primarily in 
the cochlea and saccule in the temporal bones of two patients with MD. They suggested that 
this dilation may be due to an excess of endolymph. This dilation of the endolymphatic space 
is now referred to as endolymphatic hydrops, and is associated with MD (Lopez-Escamez, 
Carey, Chung, Goebel, Magnusson, Mandalà, Newman-Toker, Strupp, Suzuki, Trabalzini, & 
others, 2015). Endolymphatic hydrops is theorised to cause the symptoms seen in MD due to 
mechanical deformation of auditory and vestibular structures (Baloh et al., 2010). 
Post mortem temporal bone studies are the most accurate way to assess 
endolymphatic hydrops. A recent meta-analysis of 53 temporal bone studies found that the 
1995 criteria for MD had a sensitivity of 31.8%  and a specificity of 100% for endolymphatic 
hydrops (Foster & Breeze, 2013). This indicates that endolymphatic hydrops always occurs in 
patients that meet the 1995 criteria for MD. However the criteria miss many patients with 
endolymphatic hydrops, suggesting that the criteria are not sensitive enough for 
endolymphatic hydrops. One limitation of the study was that they did not clearly define what 
level of the criteria they considered to be MD.
Foster and Breeze (2013), based on personal experience, estimated that 6% of people 
have asymptomatic endolymphatic hydrops. In another temporal bone study, 26% of controls 
had endolymphatic hydrops (Merchant, Adams, & Nadol, 2005. Foster and Breeze (2013)
suggested that the existence of asymptomatic endolymphatic hydrops, along with extensive 
endolymphatic hydrops seen in case studies of patients recently diagnosed with MD (Hallpike 
& Cairns, 1938; Hallpike & Wright, 1939), supports a causative role of endolymphatic 
hydrops in MD.
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Another meta-analysis of 184 temporal bone specimens with endolymphatic hydrops 
(93 with MD, 91 without) looked at the location of the hydrops (Pender, 2014). They found 
endolymphatic hydrops most commonly in the cochlea (100% of cases), followed by the 
saccule (42%), followed by the utricle (28%), and lastly the SCCs (7%). The endolymphatic 
hydrops never occurred in the less common temporal bone regions, without simultaneous 
endolymphatic hydrops in the more common areas. Because of this, Pender (2014) suggested 
that endolymphatic hydrops starts in the cochlea before spreading to the saccule, the utricle, 
and lastly the semi-circular canals.
While evidence for the association between endolymphatic hydrops and MD is 
quite strong, the cause of endolymphatic hydrops is less clear. The classical model suggested
that endolymphatic hydrops is due a blockage of the flow of endolymph, causing a build-up 
of endolymph (Schuknecht & Rüther, 1991). Indeed, blockage of the endolymphatic duct 
produces endolymphatic hydrops in guinea pigs (Kimura & Schuknecht, 1965). There is also
evidence from imaging studies that the reuniting duct, saccular duct, and the endolymphatic 
sinus are harder to visualise in MD and therefore may be occluded (Yamane et al., 2010; 
Yamane et al., 2012; Takano, Iguchi, Sakamoto, Yamane, & Anniko, 2013). Yamane and 
colleagues (2010) have suggested that the blocking material could be detached saccular 
otoconia (similar to detached otoconia found in benign paroxysmal positional vertigo). It 
should be noted that studies suggest that there is very little longitudinal flow of endolymph 
(Salt, Thalmann, Marcus, & Bohne, 1986; Salt, 2001) and radial flow remains to be 
demonstrated experimentally (Salt & Plontke, 2010). This puts in doubt endolymphatic flow 
as a potential mechanism of injury.
A more recent, and potentially compatible, theory suggests that dysfunction of spiral 
fibrocytes could disrupt K+ levels (Nin et al., 2008; Hamid, 2009; Adachi et al., 2013). This 
change would theoretically result in expansion of the endolymph compartment due to osmotic 
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pressure, while also disrupting hair cell function. Consistent with this is the fact that in an 
guinea pig model of endolymphatic hydrops, spiral ligament fibrocytes are damaged prior to
the formation of endolymphatic hydrops (Shinomori, Kimura, & Adams, 2001; Momin, 
Melki, Alagramam, & Megerian, 2009). Other contributing factors to endolymphatic hydrops
have been suggested, including allergies, viruses, genetic abnormalities, diet, and vascular 
abnormalities. A “central” theory has been suggested by which multiple mechanisms can lead 
to the formation of endolymphatic hydrops (Merchant et al., 2005).
1.2.3 Vestibular Migraine
The primary differential diagnosis of MD is Vestibular Migraine (VM; previously 
referred to as migraine-associated vertigo/dizziness, migrainous vertigo and migraine-related 
vestibulopathy/dizziness). VM, after benign paroxysmal positional vertigo, is the most 
common form of episodic vertigo (Neuhauser, 2007). A large population-based study in 
Germany estimated the lifetime prevalence of VM at 0.98% (Neuhauser et al., 2006). VM
also represents between 7-11% of patients at dizziness clinics and 9% of migraine clinics
(Neuhauser, Leopold, von Brevern, Arnold, & Lempert, 2001; Brandt et al., 2005; Maione, 
2006; Ahn et al., 2009).
VM is also a highly variable condition. It is characterised by vestibular symptoms
which interfere with routine activities, lasting between seconds and days. Most vestibular 
episodes (>50%) are associated with features of migraine, such as headache, transient visual 
symptoms (visual aura) and sensitivity to light or sound (photophobia and phonophobia)
(Table 4); (Lempert et al., 2012; Headache Classification Committee of the International 
Headache Society, 2013). Migraine typically precedes vestibular symptoms by 8-19 years 
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(Neuhauser et al., 2001; Cohen, Bigal, & Newman, 2011; Boldingh, Ljøstad, Mygland, & 
Monstad, 2013).
Table 3. Current Clinical Definition of VM (Headache Classification Committee of the 
International Headache Society, 2013).
At least five episodes fulfilling criteria B and C
A. A current or past history of Migraine without aura or Migraine with aura.
B. Vestibular symptoms of moderate or severe intensity, lasting between 5 minutes and 
72 hours.
C. At least 50% of episodes are associated with at least one of the following three 
migrainous features:
1. headache with at least two of the following four characteristics:
a) unilateral location
b) pulsating quality
c) moderate or severe intensity
d) aggravation by routine physical activity
2. photophobia and phonophobia
3. visual aura
Not better accounted for by another ICHD-3 (The International Classification of Headache 
Disorders 3rd edition) diagnosis or by another vestibular disorder.
The vestibular symptoms are extremely varied and can include spontaneous, 
positional, visually-induced, and head motion-induced vertigo or dizziness with nausea
(Table 5); (Headache Classification Committee of the International Headache Society, 2013).
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These various forms of vestibular symptoms combined with the fact that migraine symptoms 
are also variable and are not associated with every vertigo episode (Table 4; Neuhauser et al., 
2001), can make the diagnosis of VM troublesome. The duration of attacks is also extremely 
variable, ranging from seconds to days (Neuhauser et al., 2001; Neuhauser et al., 2006; 
Maione, 2006; Celebisoy, Gokcay, Sirin, & Bicak, 2008; Ahn et al., 2009; Boldingh, Ljøstad, 
Mygland, & Monstad, 2011; Radtke et al., 2011; Radtke et al., 2012; Boldingh et al., 2013; 
Shin et al., 2013; Cho et al., 2016).
Table 4. Prevalence of vestibular symptoms in patients with VM.
Symptom % (SD; Range) References
Spinning vertigo 60.4 (17.6; 30-
81.6)
(Neuhauser & Lempert, 2004; Brevern, 
Zeise, Neuhauser, Clarke, & Lempert, 
2005; Neuhauser et al., 2006; Akdal, 
2008; Ahn et al., 2009; Hassan, El-
Raouf, & Awad, 2010; Cohen et al., 
2011; Radtke et al., 2011; Radtke et al., 




(Neuhauser et al., 2006; Cohen et al., 
2011; Eggers et al., 2011; Radtke et al., 




(Neuhauser & Lempert, 2004; Brevern 
et al., 2005; Neuhauser et al., 2006;
Akdal, 2008; Ahn et al., 2009; Hassan et 
al., 2010; Radtke et al., 2011; Radtke et 




(Neuhauser & Lempert, 2004; Brevern 
et al., 2005; Neuhauser et al., 2006;
Akdal, 2008; Ahn et al., 2009 Hassan et 
al., 2010; Radtke et al., 2012; Boldingh 
et al., 2013)
Oscillopsia 43 (9.9; 36-50) (Brevern et al., 2005; Neuhauser et al., 
2006)
Dizziness 39 (42.4; 9-69) (Neuhauser et al., 2006; Eggers et al., 
2011)
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Table 5. Migraine symptoms associated with vertigo in VM
Symptom % (SD; range) References
Migrainous headache
76.4 
(15.3; 48 - 94.7)
(Neuhauser et al., 2001;
Brevern et al., 2005; 
Neuhauser et al., 2006; 
Maione, 2006; Ahn et al., 
2009; Hassan et al., 2010;
Cohen et al., 2011; Radtke et 
al., 2011; Radtke et al., 2012; 
Boldingh et al., 2013; Lopez-




(Neuhauser et al., 2001;
Brevern et al., 2005;
Neuhauser et al., 2006; 
Maione, 2006; Ahn et al., 
2009; Radtke et al., 2011; 
Radtke et al., 2012; Lopez-




(Neuhauser et al., 2001; 
Brevern et al., 2005; 
Neuhauser et al., 2006; Ahn 
et al., 2009; Radtke et al., 
2012; Boldingh et al., 2013; 




(Neuhauser et al., 2001; 
Neuhauser et al., 2006; 
Brevern et al., 2005;Ahn et 
al., 2009; Radtke et al., 2012; 
Boldingh et al., 2013; Lopez-
Escamez et al., 2014)
Osmophobia 15 (Brevern et al., 2005)
The variability of diagnostic findings in vestibular migraine is further confounded by 
the fact that traditional bedside and oculomotor vestibular tests produce variable results in 
VM (Table 6). As for MD, diagnostic testing in VM typically is performed during the 
interictal period, presumably for the same reasons (patients are typically bedridden during the 
course of attacks, and there is typically a lengthy period before a patient can see a specialist). 
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Studies have shown rates of abnormal bedside and oculomotor test results in interictal VM 
anywhere between 15% and 78% (Dieterich & Brandt, 1999; Iwasaki et al., 2007; Celebisoy 
et al., 2008; Teggi et al., 2009; Radtke et al., 2012; Shin et al., 2013; Lee, Jung, Chung, & 
Suh, 2013; Neugebauer, Adrion, Glaser, & Strupp, 2013), and in ictal VM between 70-100% 
of patients (Brevern et al., 2005; Hassan et al., 2010; Polensek & Tusa, 2010). The difference 
in abnormal findings between studies may be partially explained by progression of the 
disease. Two longitudinal studies of patients with VM found increasing rates of oculomotor 
abnormalities with increasing duration of VM (Radtke et al., 2012; Neugebauer et al., 2013).
Both central oculomotor dysfunctions (in 9-63% of patients) and peripheral 
oculomotor dysfunctions are common during the interictal period (in 12-46% of patients;
Dieterich & Brandt, 1999; Celebisoy et al., 2008; Teggi et al., 2009; Hassan et al., 2010;
Radtke et al., 2012; Lee et al., 2013; Neugebauer et al., 2013). One of the most common 
findings in both ictal and interictal VM is static positional nystagmus (Hassan et al., 2010;
Polensek & Tusa, 2010; Radtke et al., 2012; Boldingh et al., 2013). Nystagmus in VM can 
be vertical, horizontal or torsional, and can be direction changing (Brevern et al., 2005;
Vitkovic, Paine, & Rance, 2008; Teggi et al., 2009; Hassan et al., 2010; Polensek & Tusa, 
2010; Boldingh et al., 2013).
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Table 6. Results of bedside and oculomotor vestibular tests in VM during the interictal 
period. * = during ictal period.
Test









(Dieterich & Brandt, 1999*; Brevern et al., 
2005*; Furman, Sparto, Soso, & Marcus, 
2005; Maione, 2006; Iwasaki et al., 2007;
Vitkovic et al., 2008; Celebisoy et al., 2008;
Teggi et al., 2009; Hassan et al., 2010*;
Polensek & Tusa, 2010*; Nafie et al., 2011; 
Radtke et al., 2012; Boldingh et al., 2013; 
Neugebauer et al., 2013)
Gaze-evoked 
Nystagmus
7.3 (11.3; 0- 27)
23.8* (19.4; 10-37.5)*
(Dieterich & Brandt, 1999*;(Brevern et al., 
2005*; Furman et al., 2005; Celebisoy et al., 
2008; Radtke et al., 2012; Boldingh et al., 






(Dieterich & Brandt, 1999*; Brevern et al., 
2005*; Furman et al., 2005; Maione, 2006;
Hassan et al., 2010* Polensek & Tusa, 
2010*; Nafie et al., 2011; Radtke et al., 
2012; Boldingh et al., 2013)
Vibration induced 
nystagmus




30.5 (6.4; 26, 35)*
(Maione, 2006*; Iwasaki et al., 2007; Akdal, 
2008; Polensek & Tusa, 2010*; Nafie et al., 
2011; Radtke et al., 2012; Neff et al., 2012; 




(Cutrer & Baloh, 1992; Reploeg & Goebel, 
2002;  Furman et al., 2005; Radtke et al., 
2012; Iwasaki et al., 2007; Akdal, 2008; 
Celebisoy et al., 2008; Teggi et al., 2009; 
Wang et al., 2009; Dieterich & Brandt, 
1999; Vitkovic et al., 2008; Nafie et al., 
2011; Gode et al., 2012; Neff et al., 2012; 
Boldingh et al., 2013; Shin et al., 2013; 
Sharon & Hullar, 2014; Blödow et al., 2014; 
Chen, Chang, Chen, & Tseng, 2015; Kang et 
al., 2016; Morganti et al., 2016; Yoo et al., 
2016)
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Table 6 continued. Results of bedside and oculomotor vestibular tests in VM during the 
interictal period. * = during ictal period. 
Test







(Dieterich & Brandt, 1999*; Vitkovic et al., 
2008; Teggi et al., 2009; Neff et al., 2012; 
Boldingh et al., 2013)
vHIT 12.2 (4.5-28.6)
(Blödow et al., 2014; Rambold, 2014; Kang 




58 (Vitkovic et al., 2008)
Rotatory Chair 
(SVT)




(Brevern et al., 2005*; Iwasaki et al., 2007;  
Boldingh et al., 2013; Radtke et al., 2012)
Subjective vertical 1.3 (1.8; 0-2.6)





(Celebisoy et al., 2008; Teggi et al., 2009; 
Neff et al., 2012; Radtke et al., 2012; 





(Dieterich & Brandt, 1999*; Celebisoy et al., 
2008; Teggi et al., 2009; Radtke et al., 2012; 
Neff et al., 2012 Boldingh et al., 2013; 
Neugebauer, Adrion, Glaser, & Strupp, 
2013; Chen et al., 2015)
There have also been numerous case studies of hearing loss in patients with migraine 
(Lipkin, Jenkins, & Coker, 1987; Viirre & Baloh, 1996; Olsson, 1991; Parker, 1991; Lee, 
Lopez, Ishiyama, & Baloh, 2000; Lee, Whitman, & Lim, 2003; Piovesan, Kowacs, Werneck, 
& Siow, 2003; Evans & Ishiyama, 2009; Radtke et al., 2012; Chu et al., 2013). However it 
should be noted that, in VM, hearing loss is typically uncommon and non-fluctuating and
occurs primarily in the high frequencies (Brevern et al., 2005; Lempert & Neuhauser, 2009; 
Radtke et al., 2012).
DIFFERENTIAL DIAGNOSIS OF MD AND VM 34
Because of the variability of findings in vestibular tests and the absence of an 
objective test for VM, the diagnosis of VM is currently one of exclusion and relies primarily 
on case history (Neuhauser & Lempert, 2004; Gode et al., 2012). The case history of VM is 
also subject to significant variability between individual patients and between studies.
1.2.4 Pathophysiology of Migraine
To understand the pathophysiology of vestibular migraine, it is useful to look at the 
current understanding of the pathophysiology of migraine. The sensation of migraine 
headache pain is believed to be due to the sensitisation of nociceptive trigeminal sensory 
afferents (Pietrobon & Moskowitz, 2013). Ascending trigeminal sensory afferents project
from the meninges to nuclei in the brainstem, hypothalamus, and the ventral posteromedial 
nucleus of thalamus. The thalamus is then believed to integrate and process nociceptive 
inputs, in conjunction with various cortical regions (Akerman, Holland, & Goadsby, 2011).
The cause of sensitization of the trigeminal pathway is currently unknown. However 
the prevalent theory is that migraine is caused by inflammation of the pia, dura mater, and the 
cranial blood vessels (Pietrobon & Moskowitz, 2013; Espinosa-Sanchez & Lopez-Escamez, 
2015). This would result in release of vasoactive proinflammatory peptides (including 
calcium gene-related protein, substance P, and neurokinin A) and activation and sensitization 
of the trigeminal afferents. The activation and sensitization would then spread to the 
brainstem, thalamus and cortical regions, producing the varied symptoms seen in migraine. It 
has been noted that due to the heterogeneity of the disorder there may be several mechanisms 
that induce migraine (Pietrobon & Moskowitz, 2013). 
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About 15% of patients with migraine will experience a transient focal neurological 
symptom known as aura (Diener, 2016). In 90% of patients with aura these symptoms are 
visual, but can also include disturbances to other sensory modalities and speech. Aura 
typically follows a different time course from other symptoms associated with migraine, in 
that it typically precedes migraine headache and is of a much shorter duration (5 to 60 
minutes for aura compared with 4 to 72 hours for migraine headache); (Headache 
Classification Committee of the International Headache Society, 2013). Cortical spreading 
depression is currently believed to be the physiological correlate of aura. Cortical spreading 
depression is a slowly expanding (2-6mm min-1) wave of glial and neuronal depolarisation 
across the cortex. Human studies indicate that it usually begins in the occipital lobe, 
consistent with visual aura being the most common form (Akerman et al., 2011). It has been 
suggested that cortical spreading depression may be a mechanism for inducing migraine
headache by sustained nociceptive sensitization (Levy, 2012).
1.2.5 Pathophysiology of Vestibular Migraine
In contrast to migraine, very little is known about vestibular migraine. Controversy 
continues to exist over whether VM is a central or peripheral condition (Millen, Schnurr, & 
Schnurr, 2011). VM is believed to be caused by interactions in the afferent circuitry of the 
vestibular system and nociceptive systems (Espinosa-Sanchez & Lopez-Escamez, 2015).
Potential central interactions have been suggested such as the thalamus and the brainstem at 
the parabrachial nucleus (which receives projections from both the vestibular nucleus and the 
trigeminal nucleus; Balaban, 2011). These central interactions may either facilitate the 
sensitization of the nociception system in response to vestibular stimulation or enable 
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migraine to produce vestibular symptoms by sensitizing the vestibular system (Espinosa-
Sanchez & Lopez-Escamez, 2015). Cortical spreading depression has also been offered as a 
potential central cause for vestibular symptoms (Dieterich & Brandt, 1999). This has been 
suggested as unlikely as vestibular symptoms typically last between seconds to days, which is 
not consistent with the duration of aura (Liu & Xu, 2016).
Another potential interaction between the vestibular and nociceptive systems is at the 
inner ear. The inner ear is innervated by the trigeminal nerve via the basilar artery and the 
anterior inferior cerebellar artery (Espinosa-Sanchez & Lopez-Escamez, 2015). Trigeminal 
nerve fibres project to the stria vascularis, dark cells in the vestibular labyrinth and the spiral 
modiolar blood vessels (Vass, Shore, Nuttall, & Miller, 1998). Electrical stimulation of the 
trigeminal nerve results in increased vascular permeability and leakage of plasma at the 
basilar and the anterior inferior cerebellar arteries (Vass et al., 2001). Intravenous serotonin 
(5-HT)-induced vascular permeability results in leakage of plasma into the apical spiral 
ganglion, the modiolus, and intralabyrinthine segments of the superior and inferior nerves
(Koo & Balaban, 2006). This leakage of plasma has been proposed to result in increased 
inner ear fluid pressure and altered ion homeostasis, therefore leading to peripheral vestibular 
symptoms in VM (Vass et al., 2004; Koo & Balaban, 2006). Figure 5 shows a current model 
of VM proposed by Furman, Marcus, and Balaban (2013).
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Figure 5. Proposed vestibular migraine pathways. Serotonin (5-HT), Noradrenaline (NA);
(Adapted from Furman, Marcus, & Balaban, 2013).
1.2.6 Differentiating MD from VM
As mentioned earlier, both MD and VM are currently diagnosed primarily on case 
history and exclusion of other conditions. This is not ideal for two reasons. Firstly, patients 
often find it difficult to articulate their symptoms (Stolte, Holle, Naegel, Diener, & 
Obermann, 2015). Secondly, there is a significant overlap in the symptoms of VM and MD, 
as patients with VM can present with auditory symptoms during episodes (Table 7), while 
migraine symptoms are frequently associated with vestibular symptoms in MD (Table 8).
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Table 7. Cochlear symptoms during VM episodes.
Symptom % (SD; Range) References
Hearing loss 23.5 (13.8; 0-44)
(Brevern et al., 2005;
Maione, 2006; Neuhauser et 
al., 2006; Eggers et al., 2011;
Radtke et al., 2011; Radtke et 
al., 2012; Neff et al., 2012
Lopez-Escamez et al., 2014; 
Lepcha, Tyagi, Ashish, 
Augustine, & Balraj, 2015; 
Morganti et al., 2016)
Tinnitus 31.0 (22.8; 0-69)
(Brevern et al., 2005;
Maione, 2006; Neuhauser et 
al., 2006; Iwasaki et al., 
2007; Eggers et al., 2011; 
Radtke et al., 2011; Radtke et 
al., 2012; Neff et al., 2012; 
Lopez-Escamez et al., 2014; 
Morganti et al., 2016)
Aural Fullness 32.6 (19.5; 11-70)
(Brevern et al., 2005; 
Neuhauser et al., 2006; 
Iwasaki et al., 2007; Radtke 
et al., 2011; Eggers et al., 
2011; Radtke et al., 2012;
Neff et al., 2012; Lopez-
Escamez et al., 2014; 
Morganti et al., 2016)
DIFFERENTIAL DIAGNOSIS OF MD AND VM 39
Table 8. Migrainous symptoms during MD episodes.
Symptom % (SD; Range) References
Migrainous headache 42.5 (41.0; 8.4-88)
(Neff et al., 2012;
Shin et al., 2013; Lopez-
Escamez et al., 2014)
Photophobia 33.1 (13.1; 18-41.2)
(Neff et al., 2012; Shin et al., 
2013; Lopez-Escamez et al., 
2014)
Phonophobia 48.4 (24.6; 20-63)
(Neff et al., 2012; Shin et al., 
2013; Lopez-Escamez et al., 
2014)
Aura 12.3 (9.1; 4-22)
(Neff et al., 2012; Shin et al., 
2013; Lopez-Escamez et al., 
2014)
While it has been suggested that the issue of differential diagnosis is difficult in the 
early stages of MD and VM, evidence suggests that issues persist even after a diagnosis is 
made. 13% of patients of definite VM also fulfilled the criteria for bilateral MD (Radtke et 
al., 2011). Other studies have found 17-23% of patients with VM also meet the criteria for 
MD (Eggers et al., 2011; Neff et al., 2012) and 28-41% of patients with MD also meet the 
criteria for VM (Neff et al., 2012; Ghavami, Mahboubi, Yau, Maducdoc, & Djalilian, 2016). 
These findings suggest that there is a significant overlap of the diagnostic criteria for the two 
conditions, and therefore the diagnostic criteria alone are not sufficiently discriminative.
1.2.7 VM and MD – A common pathophysiology?
One attempt to explain the overlap between VM and MD is that they share a common 
pathophysiology. Several studies have found that the rate of migraine is higher in patients 
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with MD (Hinchcliffe, 1967; Morrison, 1981; Radtke et al., 2002; Sen, Georgalas, & 
Papesch, 2005; Ibekwe et al., 2008; Ghavami et al., 2016). However, another study found the 
rate of migraine was not different for patients with MD when compared with controls 
(Rassekh & Harker, 1992). Furthermore, a large population-based study found that the 
incidence of migraine in MD was similar to that of the general population (Gopen, Viirre, & 
Anderson, 2009). One explanation is that vertigo may act as a migraine trigger. Indeed, one 
study found that 49% of patients with migraine experienced a migraine within 24 hours of 
having caloric/rotatory chair testing (Murdin, Davies, & Bronstein, 2009).
One of the mechanisms first suggested for a shared pathology between VM and MD is
an ischemic event resulting from migraine-induced vasospasm (Atkinson, 1962 as cited by 
Evans & Ishiyama, 2009; Parker, 1991; Viirre & Baloh, 1996). Three cases of sudden 
sensori-neural hearing loss following migraine have been reported that are consistent with an 
ischemic insult (Lee et al., 2000; Lee et al., 2003).  However, the vasospasm theory of 
migraine has fallen out of favour due to a lack of evidence (Tfelt-Hansen, 2010).
It has been suggested that VM and MD may share a genetic cause (Baloh, 1997;  
Oliveira, Bezerra, Araujo, Almeida, & Messias, 1997; Oliveira, Messias, & Ferrari, 2002; 
Cha, Kane, & Baloh, 2008). Studies have identified families in which migraine and MD were 
highly associated, suggesting a shared heritability (Oliveira et al., 1997; Oliveira et al., 2002;
Cha et al., 2008). In particular, it has been suggested that both conditions may be 
channelopathies (Radtke et al., 2002). Multiple instances of ion channel mutations have been 
identified in families who show high instances of migraine and MD (Baloh, 1997). There is 
also a high rate of mutations in aquaporin 3, a water channel, in patients with MD (Candreia, 
Schmuziger, & Gürtler, 2010). Mutations in such channels could potentially result in both 
central and peripheral disorders (Baloh, 1997).
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Allergy has also been suggested as a common cause of VM and MD (Sen et al., 
2005). Several studies have noted higher rates of allergy in patients with MD (Banks, 
McGinness, Harvey, & Sacks, 2012) and patients with migraine (Mehle, 2012) when 
compared to healthy controls. Additionally patients with MD and migraine self-report higher 
rates of allergy than patients with MD but without migraine (Sen et al., 2005). 
Another explanation is vasoactive neuropeptide release from vascular trigeminal 
nerve fibres (Cutrer & Baloh, 1992; Vass et al., 2004; Koo & Balaban, 2006). There is 
evidence that trigeminal nerve fibres project to the stria vascularis, dark cells in the vestibular 
labyrinth and the spiral modiolar blood vessels (Vass et al., 1998). Electrical stimulation of 
the trigeminal nerve results in increased vascular permeability and leakage of plasma at the 
basilar and the anterior inferior cerebellar arteries (Vass et al., 2001). 5-HT induced vascular 
permeability results in leakage of plasma into the apical spiral ganglion, and the modiolus, 
and intralabyrinthine segments of the superior and inferior nerve (Koo & Balaban, 2006). 
This leakage of plasma has been proposed to result in increased inner ear fluid pressure, in 
the form of endolymphatic hydrops, and altered ion homeostasis. These changes could
produce the peripheral vestibular and auditory symptoms in vestibular migraine (Vass et al., 
2004; Koo & Balaban, 2006).
1.3 Diagnostic Accuracy
The main model for assessing the effectiveness of a diagnostic test is diagnostic 
accuracy. Diagnostic accuracy refers to the amount of agreement between the results of a 
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diagnostic test of interest (index test) and the results of the best available diagnostic 
procedure (reference standard). In studies of diagnostic accuracy, an index test is compared to 
the reference standard to determine the diagnostic accuracy of the index test (Linnet, Bossuyt, 
Moons, & Reitsma, 2012). Diagnostic accuracy studies operate on the assumption that 
differences between the index and reference test are due to errors in the index test (Van 
Rijkom & Verdonschot, 1995; Biesheuvel, Irwig, & Bossuyt, 2007).
There are several measures of diagnostic accuracy. The fundamental measures include 
sensitivity, specificity, and accuracy and are calculated using a 2 x 2 table (Figure 6). 
Sensitivity (TP/(FN+TP)) is the proportion of positive reference test results that the index test 
correctly classifies. Specificity (TN/(TN + FP)) is the proportion of negative reference test 
results that the index test correctly classifies. Accuracy ((TN+TP)/(TN+TP+FP+FN)) is the 
overall proportion of people that the index test correctly classifies (Linnet et al., 2012).
Reference Test
Test Result Positive Negative
Index Test
Positive True Positive (TP) False Positive (FP)
Negative False Negative (FN) True Negative (TN)
Figure 6. 2-by-2 table for estimating diagnostic accuracy.
1.3.1 Importance of Diagnostic Accuracy
Improved diagnostic accuracy is important as it can improve patient outcomes in 
several ways. These improvements of outcome can occur by way of earlier diagnosis, 
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reduced numbers of visits to health care professionals, improved prognostic information, 
better therapeutic decisions, and reassurance for the patient as to the presence or absence of a 
condition (Fineberg, 1977; Schünemann et al., 2008; Vassiliou, Vlastarakos, Maragoudakis, 
Candiloros, & Nikolopoulos, 2011; Bossuyt, Reitsma, Linnet, & Moons, 2012; Lin & 
Aligene, 2013). Additionally improved diagnostic accuracy would theoretically improve the 
quality of patient populations in clinical trials, giving a better indication of the efficacy of 
different therapeutics. While none of these benefits are guaranteed, the endeavour to improve 
the diagnostic accuracy of MD and VM has many potential advantages.
1.4 Systematic Reviews
Systematic reviews and are considered superior to traditional reviews (such as 
narrative or literature review) for synthesising evidence in health care. This is due to the 
innate bias associated with traditional reviews, as the methodology is not reported and is not 
systematic (McGowan, 2012). Several guidelines on recommended protocols for systematic 
reviews exist such as the preferred reporting items for systematic reviews and meta-analyses
(PRISMA; Moher, Liberati, Tetzlaff, Altman, & Group, 2009) , the Joanna Briggs Institute
Reviewers Manual (Campbell et al., 2015), and the Cochrane Handbook for Systematic 
Reviews of Interventions (Higgins & Green, 2011).
Systematic review methodologies, while having some differences, still approximately
follow the four steps outlined by Goldschmidt (1986): 1) Develop a well-defined research 
question and inclusion criteria. 2) Develop a systematic search strategy and collect relevant 
articles according to the inclusion criteria. 3) Assess the methodological validity (or bias) of 
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studies in a systematic way. 4) Present the process and the informational outcome of the 
systematic review.
1.4.1 Systematic Reviews of Diagnostic Accuracy
Systematic reviews of diagnostic accuracy provide a transparent overview of the 
literature for the accuracy of a diagnostic test or tests. They also enable the pooling of results
from several studies to provide a more statistically powerful analysis of diagnostic tests than 
individual studies (Reitsma, Moons, Bossuyt, & Linnet, 2012).
Special considerations arise when conducting systematic reviews of diagnostic 
accuracy. Studies of diagnostic accuracy are prone to different forms of bias than other 
studies (Whiting, Rutjes, Westwood, & Mallett, 2013). Recent initiatives have aimed to 
improve the quality of diagnostic studies. These include the Standards for Reporting of 
Diagnostic Accuracy (STARD) initiative, which guides diagnostic accuracy studies on how 
to report their findings so that sources of bias are better reported (Bossuyt et al., 2003; 
Ochodo & Bossuyt, 2013), and  Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS)-2 (Whiting et al., 2011), which was designed to be used as a tool for
systematically assessing bias in diagnostic accuracy studies. Both highlight common sources 
of bias in diagnostic accuracy studies, and therefore provide a valuable resource to 
researchers conducting systematic reviews and primary diagnostic studies.
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1.4.2 Scoping Reviews
A subtype of the systematic review methodology is the scoping review (also referred 
to as a mapping review). Scoping reviews typically follow the same methodology as 
systematic reviews. The primary distinction is that scoping reviews do not typically assess the 
methodological validity or bias of selected studies. Instead scoping reviews aim to give an 
overview of the current evidence in an area, regardless of quality (Peters et al., 2015). 
Because of this, scoping reviews have a limited scope for impacting on health care, but are 
useful for providing an overview of a large body of literature and for providing direction for 
future research (Arksey & O’Malley, 2005). There are several guidelines for conducting a 
scoping reviews (Arksey & O’Malley, 2005; Levac, Colquhoun, & O’Brien, 2010; Peters et 
al., 2015). 
1.4.3 Search Filters for Systematic Reviews
Search terms (in systematic reviews) can be described in terms of their sensitivity (the 
proportion of relevant articles retrieved by a search) and specificity (the proportion of 
irrelevant articles not retrieved by a search). A priority is placed on sensitivity when choosing 
search terms, as systematic reviews should endeavour to include as many relevant papers as 
possible (Higgins & Green, 2011). However specificity can also be important as search terms 
can often return an unmanageable number of irrelevant results. Search filters are a method of 
improving the specificity of a search.
DIFFERENTIAL DIAGNOSIS OF MD AND VM 46
The use of search filters for diagnostic accuracy studies is controversial in systematic 
reviews. The Cochrane Handbook for Systematic Review of Diagnostic Test Accuracy 
recommends using terms for the index test only in combination with terms for the condition 
of interest (de Vet, Eisinga, Ripagen, Aertgeerts, & Pewsner, 2008).  Several studies also
indicate that search filters may lead to the omission of important studies (Doust, Pietrzak, 
Sanders, & Glasziou, 2005; Leeflang, Scholten, Rutjes, Reitsma, & Bossuyt, 2006; Ritchie, 
Glanville, & Lefebvre, 2007; Mann, Hewitt, & Gilbody, 2008; Whiting et al., 2011; Beynon 
et al., 2013). However the same is true of limiting a systematic review to certain databases 
(which is true of all systematic reviews; Whiting, Westwood, Burke, Sterne, & Glanville, 
2008).
The sensitive diagnostic clinical queries filters for MEDLINE (Haynes & Wilczynski, 
2004) and Embase (Wilczynski & Haynes, 2005) have been shown to maintain high 
sensitivity (90-100%) relative to unfiltered searches, while also dramatically improving 
specificity (70-74%; Haynes & Wilczynski, 2004; Wilczynski & Haynes, 2005; Leeflang et 
al., 2006; Kastner, Wilczynski, McKibbon, Garg, & Haynes, 2009; Whiting et al., 2011;
Wilczynski, McKibbon, Walter, Garg, & Haynes, 2013). It should be noted that one study 
found the MEDLINE sensitive clinical queries filter was only 69% sensitive (Ritchie et al., 
2007). However the study’s methodology was flawed, as the authors used studies that were 
not originally obtained using MEDLINE in their gold standard. Overall these studies indicate 
the filter will miss some relevant studies when compared to an unfiltered search. However, as 
long as the use of the filter and the limitations of using it are acknowledged, the sensitive 
clinical queries search filter offers a valuable method to make otherwise unmanageable 
searches possible.
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1.5 Rationale and Objectives
As mentioned earlier, the differential diagnosis of MD and VM is difficult, due to a 
reliance on symptom-based diagnosis. Despite the frequent occurrence of both conditions in 
clinics, a search of the literature identified only one non-systematic review on the topic of the 
differential diagnosis of MD and VM (Shepard, 2006), one systematic review on the topic of 
differential diagnosis in MD that did not mention VM (Vassiliou et al., 2011), and one 
systematic review on the topic of differential diagnosis in VM (Fasunla, Ibekwe, & Nwaorgu, 
2012). Fasunla and colleagues (2012) acknowledged the difficulty in differentiating VM and 
MD but did not provide any evidence base for diagnostic tests that might separate the two 
conditions.
The present study aimed to conduct a systematic review of the differential diagnosis 
of MD and VM, with a focus on diagnostic accuracy. For the purpose of this systematic 
review, any relevant diagnostic test that had been compared between MD and VM was
included. The diagnostic criteria for MD and VM were used as reference tests for the 
diagnostic tests to be compared to. This was done with the intention of establishing the 
evidence base for diagnostic separation of MD and VM.
A secondary scoping review was also conducted to examine any measures with high 
sensitivity and specificity for either MD or VM. This was conducted to identify any 
diagnostic tests that show high diagnostic accuracy but might be missed from the systematic 
review because the test was not compared in MD and VM simultaneously. The reasoning 
behind this scoping review was to identify tests that should theoretically separate MD and 
VM accurately. As will be described in section 2.4, clinical queries filters were used in the 
scoping review to make the number of search results manageable.
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2.0 Methods
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2.1 Protocol and registration 
A published review protocol exists (Osborne, 2017). The protocol was created 
according to the preferred reporting items for systematic reviews and meta-analyses
(PRISMA)-protocol guidelines (Moher et al., 2015).
2.2 Eligibility criteria
MD was defined as patients meeting either the 1995 (AAO-NHS, 1995) or 2015 
AAO-NHS diagnostic criteria (Lopez-Escamez et al., 2015; Goebel, 2016). VM was defined 
as patients meeting any of the original Neuhauser diagnostic criteria (Neuhauser, Leopold, 
von Brevern, Arnold, & Lempert, 2001; Neuhauser & Lempert, 2004; Radtke, Neuhauser, 
von Brevern, Hottenrott, & Lempert, 2011) or the diagnostic criteria defined by consensus of 
the Bárány Society and International Headache Society (Lempert et al., 2012; Headache 
Classification Committee of the International Headache Society, 2013).
Eligibility criteria for Systematic Review:
1. Article was a meta-analysis, systematic review, randomised control trial, cohort, or 
case control (prospective or retrospective).
2. Article contained patients with MD and patients with VM.
3. Article contained a measure that could be used to separate MD and VM.
4. Article was written in English.
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Eligibility criteria for Scoping Review:
1. Article was a meta-analysis, systematic review, randomised control trial, cohort, or 
case control (prospective or retrospective).
2. Article contained patients with MD and patients with VM.
3. Article contained a diagnostic test, for which sensitivity and specificity for MD or 
VM were available or could be calculated.
4. Article was written in English.
After studies meeting the above criteria for the scoping review were identified, 
diagnostic tests were identified that showed high sensitivity (>70%) and specificity (>70%) 
for MD or VM in at least one study. If a diagnostic test showed such high sensitivity and 
specificity in at least one study, all studies meeting the inclusion criteria for that diagnostic 
test with sensitivity and specificity were included. This is not a traditional PRISMA method, 
but is instead a novel approach we created to capture diagnostic tests that were accurate for 
MD, but without excluding studies that showed poorer accuracy in the identified diagnostic 
tests.
2.3 Information sources
Final searches were conducted on 27 November 2016. PubMed and Ovid (Embase) 
were used. PubMed was chosen as it provides access to MEDLINE, is updated more rapidly 
than other MEDLINE search engines, and can search article text for search terms (Kelly & St 
Pierre-Hansen, 2008). MEDLINE and Embase were chosen as they have been identified as 
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highly sensitive for diagnostic accuracy studies (Whiting, Westwood, Burke, Sterne, & 
Glanville, 2008; van Enst, Scholten, Whiting, Zwinderman, & Hooft, 2014). 
Grey/unpublished literature was not used in this study.
2.4 Search strategy
A search strategy was conducted according to the 2009 PRISMA statement (Moher et 
al., 2009). PubMed and Ovid (Embase) were searched until 27 November 2016. Filters for 
the English language, and articles after 1994 were used (as the relevant populations were 
defined by criteria set after this point). The sensitive diagnostic accuracy clinical queries 
filters were used (Haynes & Wilczynski, 2004; Wilczynski & Haynes, 2005). As mentioned 
in the introduction, the use of these filters reduces the sensitivity of a given search. However 
without the filter, 7563 studies were returned. This was considered to be an impractical 
amount and so the filters were used. The search strategy for the systematic review (Table 9)
and the scoping review (Table 10) are presented below.
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Table 9. Search strategy for the systematic review.
Search terms
PubMed (“meniere's” OR “meniere” OR 
“endolymphatic hydrops”) AND (“vestibular 
migraine” OR “migrainous vertigo” OR 
“migraine associated vertigo” OR “migraine 
associated dizziness” OR “migraine-related 
vestibulopathy” OR “migraine-related 
dizziness”)
Ovid (Embase) (‘meniere's’ OR ‘meniere’ OR 
‘endolymphatic hydrops’) AND (‘vestibular 
migraine’ OR ‘migrainous vertigo’ OR 
‘migraine associated vertigo’ OR ‘migraine 
associated dizziness’ OR ‘migraine-related 
vestibulopathy’ OR ‘migraine-related 
dizziness’)
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Table 10. Search strategy for the scoping review
Search terms
PubMed (“meniere's” OR “meniere” OR 
“endolymphatic hydrops” OR “vestibular 
migraine” OR “migrainous vertigo” OR 
“migraine associated vertigo” OR “migraine 
associated dizziness” OR “migraine-related 
vestibulopathy” OR “migraine-related 
dizziness”) AND (sensitiv* [Title/Abstract] 
OR sensitivity and specificity[MeSH Terms] 
OR diagnos*[Title/Abstract]OR 




Ovid (Embase) (‘meniere's’ OR ‘meniere’ OR 
‘endolymphatic hydrops’) OR (‘vestibular 
migraine’ OR ‘migrainous vertigo’ OR 
‘migraine associated vertigo’ OR ‘migraine 
associated dizziness’ OR ‘migraine-related 
vestibulopathy’ OR ‘migraine-related 
dizziness’) AND (di.fs. OR predict:.tw. OR 
specificity.tw.)
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2.5 Study Selection and Data Collection Process
One author (JO) read abstracts from the initial search results to screen whether the 
studies were potentially relevant to the current systematic review. The articles of all selected 
abstracts were then read to determine whether the articles meet the eligibility criteria. Data 
from studies was tabulated using a Microsoft Excel spreadsheet. QUADAS-2 was used to 
assess bias in individual studies (Whiting et al., 2011).
2.6 Data Items
Measures included the country in which the articles were conducted, the diagnostic 
criteria used to diagnose MD and VM, the diagnostic tests used in each study, measures of 
diagnostic accuracy, cut-off values, and bias using the QUADAS-2 items (Whiting et al., 
2011). Where a measure of diagnostic accuracy was not available, a 2 x 2 table was 
constructed based on available information if possible. Where a 95% confidence interval (CI) 
of the control group was used to define the cut-off value, and specificity was not reported, the 
n value that gave the closest value to 95% specificity was used in the 2 x 2 table.
2.7 Synthesis of Results
For the systematic review and scoping review, forest plots of sensitivity and 
specificity were created. Forest plots show a point estimate (in the form of a square) for each 
study with a horizontal line which typically indicates the 95% CI (Lewis & Clarke, 2001). A 
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narrative summary was also produced. For the scoping review no further analysis was 
performed.
Heterogeneity was assessed using I2 (Higgins & Thompson, 2002; Higgins, 
Thompson, Deeks, & Altman, 2003). Hierarchical summary receiver operating characteristics
(HSROC); (Rutter & Gatsonis, 2001) were calculated for each test where appropriate. This is 
currently the recommended method for summary statistic for meta-analyses of diagnostic 
accuracy (over traditional summary receiver operating characteristics), as it takes into 
account the relationship between sensitivity and specificity, while also accounting for 
heterogeneity by using study- and patient-level covariates (Lee, Kim, Choi, Huh, & Park, 
2015; Dinnes, Mallett, Hopewell, Roderick, & Deeks, 2016). 
Meta-bias was intended to be assessed using the arcsine square-root transformed risk 
difference model including random effects (Rücker, Schwarzer, Carpenter, & Olkin, 2009), 
as this model was recommended for dichotomous outcome measures in a recent consensus 
document on funnel plot asymmetry (Sterne et al., 2011).
The quality of evidence was evaluated using the Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) system (Guyatt et al., 2011). Case-
control and cohort studies were considered to start as high quality evidence, before being 
modified, as recommended when reviewing diagnostic accuracy studies (Schünemann et al., 
2008).
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2.8 Software
Microsoft Excel, R x64 3.3.2, Meta-DiSc version 1.4 and Revman 5.3.5 were used. 
Forest plots were produced using Revman. I2 was calculated using Meta-DiSc. HSROC 
figures were produced using the HSROC package for R (Schiller & Dendukuri, 2015). 
Funnel plots and bias measures were produced using the meta4diag package for R. These 
software were all freely available for non-commercial use (with the exception of Microsoft 
Excel).
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3.0 Results of the Systematic Review
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3.1 Included studies
Eighteen studies met the inclusion criteria and were included in the systematic review 
(Figure 7). Seven studies were prospective case-control in design, two were retrospective 
case-control, two were prospective cohort, and seven were retrospective cohort (Table 11). 
Measures that were covered by articles in the systematic review included symptoms, 
caloric testing, head shaking nystagmus (HSN), vibration-induced nystagmus (VIN), vHIT, 
cervical vestibular evoked myogenic potentials (cVEMPs), ocular vestibular evoked 
myogenic potentials (oVEMPs), posturography, linear motion perception thresholds (LMPT), 
rotatory chair testing, and extratympanic click electrocochleography (ECoG).
All papers contained multiple sources of bias (Table 12). Common sources of bias 
included inappropriate exclusions in the patient group (such as patients with migraine, 
bilateral symptoms or hearing loss), case-control design, lack of blinding, use of 
probable/possible diagnostic criteria (inappropriate reference standard), and use of cut-off 
points that were determined post-hoc.
One study met the inclusion criteria, but was excluded (Mahringer & Rambold, 2014). 
The excluded study was a retrospective cohort that looked at vHIT in MD and VM, among 
other conditions (Mahringer & Rambold, 2014). The study was excluded because only 
patients with abnormal caloric results were included in their analysis. 
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Figure 7. PRISMA flowchart for the systematic review.
Records identified from PubMed 
(n= 110) and Ovid (Embase) 
(n=216)
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Table 12. QUADAS-2 assessment.
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3.2 Symptoms
Five of the identified studies compared symptoms between patients with MD 
and VM (Neff et al., 2012; Shin et al., 2013; Lopez-Escamez et al., 2014; Chang & Hsu, 
2014; Sharon & Hullar, 2014).
Features associated with the diagnostic criteria (auditory symptoms, migraine 
features, duration of attacks) were all significantly different between patients with MD and 
VM (Neff et al., 2012; Lopez-Escamez et al., 2014). Other studies also noted differences 
between groups with respect to these, but did not compare them statistically (Shin et al., 
2013). Despite differences, most symptoms showed a large degree of overlap, particularly 
between MD and probable VM (Lopez-Escamez et al., 2014) or when patients meeting the 
criteria for both definite MD and definite VM were factored in (Neff et al., 2012).
A history of progressive hearing loss (93% sensitive and 78% specific) and having a 
pure tone average greater than 25 dB HL (100% sensitive and 91% specific) were best for 
distinguishing patients with MD from patients with VM (Neff et al., 2012). However these 
measures did not separate patients with MD from patients with both VM and MD (Neff et al., 
2012). It is important to note that these differences are likely to be due to applying the 
diagnostic criteria, and therefore any association with the criteria is expected.
Demographic features are different between patients with MD and VM. 
Patients with MD tend to be older at disease onset than patients with VM (Neff et al., 2012; 
Lopez-Escamez et al., 2014), and are more likely to be male (Neff et al., 2012). Attacks were 
more frequent in VM (Neff et al., 2012).
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Car sickness and motion sickness appear to provide some separation. Car sickness 
was experienced by 78% of patients with VM in their lifetime, compared with only 18.2% of 
patients with MD (Chang & Hsu, 2014). Another study also found motion sickness was more 
common in patients with VM (51%) than in patients with MD (20%); (Neff et al., 2012). 
Sharon & Hullar (2014) found that scores on a motion sensitivity questionnaire were 
significantly higher for patients with definite VM when compared to patients with MD. 
However the scores did not differ significantly when patients with probable VM were 
included in the VM group.
Comorbidity of chronic subjective dizziness was more common in patients 
with VM (41%) than patients with MD (4%); (Neff et al., 2012). Interestingly family history 
was more common in patients who met the criteria for both MD and VM (Neff et al., 2012). 
This is consistent with the suggestion that the comorbid presentation of MD and VM may 
actually represent a genetic disorder distinct from the individual conditions (Cha & Baloh, 
2007).
3.3 Caloric testing
In caloric testing the ear is irrigated using warm and/or cold water or air, and the 
resulting nystagmus is recorded. Caloric nystagmus is believed to be due to temperature 
change of fluid in the lateral canal resulting in activation of the VOR (for a systematic review 
of caloric methodology see Gonçalves, Felipe, & Lima, 2008). Ten of the identified studies 
compared caloric results between patients with MD and VM (Neff et al., 2012; Taylor et al., 
2012); Hong et al., 2013; Shin et al., 2013; Blödow et al., 2014; Martin-Sanz et al., 2014; 
Kim et al., 2014; Sharon & Hullar, 2014; Rambold, 2015; Inoue et al., 2016). Kim and 
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colleagues (2014) used the same VM group as Shin and colleagues (2013), and were 
therefore excluded from the summary. The rate of caloric asymmetry was consistently higher 
in MD (43-75%) than VM (7-25%). Patients with MD had significantly higher asymmetry 
than patients with VM (Sharon & Hullar, 2014). Figure 8 shows the sensitivity and 
specificity of caloric asymmetry for MD when using VM as a control group. Neff and 
colleagues (2012) reported abnormal directional preponderance as having 29% sensitivity and 
85% specificity for MD, with VM as a control group; however they did not report a cut-off 
value.
As several studies using caloric in MD and VM were identified (Taylor et al., 2012); 
Hong et al., 2013; Shin et al., 2013; Blödow et al., 2014; Rambold, 2015; Inoue et al., 2016), 
an HSROC was produced (Figure 9). Three studies were excluded from further analysis due 
to lack of a cut-off point (Neff et al., 2012; Martin-Sanz et al., 2014), or lack of 2 x 2 data 
(Sharon & Hullar, 2014). There was a significant amount of heterogeneity between studies
for sensitivity (Chi2 = 16.89, df = 5, p = 0.005; I2 = 70.4 %), but not for specificity (Chi2 = 
4.00, df = 5, p = 0.549; I2 = 0.0 %). The point estimate of sensitivity was 54.6% (95% CI: 
38.7-69.0%) and point estimate of specificity 78.9% (95% CI: 70.7-87.4%), indicating that 
caloric testing would correctly identify about 55% of patients with MD and misclassify 21% 
of patients with VM.
A contour assisted funnel plot was also produced (Figure 10). The test for funnel plot 
asymmetry was negative (t = 0.4489, p = 0.6767). However funnel plot asymmetry tests 
typically have low power (Sterne et al., 2011). This combined with the fact that that no 
studies were identified in the white region (area of non-significance) indicates that
publication bias cannot be excluded as a possibility.
DIFFERENTIAL DIAGNOSIS OF MD AND VM 68
Figure 8. Forest plot of sensitivities and specificities for caloric testing when treating MD as 
a positive result and VM as a negative result. 
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Figure 9. HSROC of caloric testing, when MD is treated as a positive result and VM 
is treated as a negative result. Open circles indicates studies. The size of the circle indicates 
weighting. The blue line indicates the 95% CI of sensitivity and specificity. The red circle 
indicates the point estimate of sensitivity and specificity. The red line indicates the 95% CI of 
the point estimate. 
DIFFERENTIAL DIAGNOSIS OF MD AND VM 70
F
igure 10.C
ontour enhanced funnel plot. B
lack circles indicate included studies. N
o m
issing studies w






















0.139   0.104    0.069   0.035   0
-0
.4                                     -0
.2
                                        0                                        0.2
                                      0
.4                                        0.6













DIFFERENTIAL DIAGNOSIS OF MD AND VM 71
3.4 Rotatory chair testing
Rotatory chair testing involves recording eye movements in response to rotation, and 
is believed to measure the VOR of the horizontal SCC (Ahmed, Goebel, & Sinks, 2009). One 
study used rotatory chair testing (Neff et al., 2012). Neff and colleagues (2012) found that 
patients with MD had more abnormal results than patients with VM for rotatory chair testing. 
The rotatory chair summary measure was also identified as one of the few tests that could 
separate patients with MD from patients that met the criteria for both MD and VM. However 
Neff and colleagues (2012) did not adequately describe their methods or provide cut-off 
values.
3.5 Video head impulse test (vHIT)
The vHIT involves recording eye movements in response to sudden head impulses in 
the planes of the SCCs. vHIT enables individual testing of the six SCCs with high sensitivity 
and specificity for peripheral vestibular disorders (MacDougall, Weber, McGarvie, 
Halmagyi, & Curthoys, 2009). Three of the identified studies compared vHIT results in 
patients with MD and VM (Blödow et al., 2014; Rambold, 2015; Heuberger et al., 2014).
The sensitivities and specificities of horizontal vHIT are presented below (Figure 11). 
Blödow and colleagues (2014) found that abnormal horizontal vHIT gain was more common 
in patients with MD (37%) than VM (9%), resulting in a sensitivity of 37% and a specificity 
of 91%. Rambold (2015) found abnormal gains of 8% in of patients with MD and 4.5% of 
patients with VM. Heuberger and colleagues (2014) found that horizontal vHIT gain was not 
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significantly different between MD (17%) and VM (7%). Heuberger and colleagues (2014)
found that the presence of covert saccades was more common in MD (46%) than VM (18%).
Figure 11. Forest plot of sensitivities and specificities of horizontal vHIT when treating MD 
as a positive result and VM as a negative result. 
3.6 Head Shaking Nystagmus (HSN)
HSN is a latent nystagmus provoked by rapid passive head shaking. The nystagmus is 
believed to be due to asymmetry in the central velocity storage mechanism (Boniver, 2008).
Three papers looked at HSN; (Neff et al., 2012; Shin et al., 2013; Kim et al., 2014). Kim and 
colleagues (2014) had the same VM group as Shin and colleagues (2013). Because of this the 
duplicate data is not discussed.
The sensitivities and specificities of HSN are presented below (Figure 12). Neff and 
colleagues (2012) found abnormal HSN results in 62% of patients with definite/probable 
MD, and 15% of patients with definite/probable VM. Shin and colleagues (2013) found that 
74% of patients with definite unilateral MD and 50% of patients with definite VM had 
abnormal HSN. Kim and colleagues (2014) went on to characterise the direction of HSN in 
MD and VM. They found that the most common type was mixed (46% for MD, 57% for 
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VM), followed by horizontal (42% for MD, 30% for VM), and most rarely vertical 
nystagmus (5% for MD, 4% for VM).
Figure 12. Forest plot of sensitivities and specificities for caloric testing when treating MD as 
a positive result and VM as a negative result. 
3.7 Vibration-induced nystagmus testing (VIN)
VIN testing involves vibrating the skull of a patient, and recording the resultant 
nystagmus (for a summary of VIN methodology see Dumas, Perrin, Ouedraogo, & 
Schmerber, 2016). Two studies compared VIN in patients with VM and MD (Neff et al., 
2012; Shin et al., 2013). The sensitivities and specificities of HSN are presented below 
(Figure 13). Neff and colleagues (2012) found that 60% of patients with definite/probable 
MD had abnormal VIN, compared to 12% of patients with definite/probable VM.  Shin and 
colleagues (2013) found abnormal VIN results in 53% of patients with definite unilateral MD 
and 32% of patients with definite VM.
Figure 14. Forest plot of sensitivities and specificities of VIN when treating MD as a positive 
result and VM as a negative result.
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3.8 Cervical Vestibular Evoked Myogenic Potentials (cVEMP)
The cVEMP is a response from the sternocleidomastoid muscle of the neck produced
by loud sounds, vibration, or tap stimuli. The cVEMP is believed to reflect the VCR, and it is 
thought to originate from the saccule. (For reviews see: Rosengren, Welgampola, & 
Colebatch, 2010 or Murofushi, 2014). Seven studies compared cVEMP results between 
patients with MD and VM (Baier & Dieterich, 2009; Taylor et al., 2012; Zuniga et al., 2012; 
Bremova et al., 2016; van Tilburg et al., 2016). One study also used cVEMPs (Neff et al., 
2012). However they did not adequately describe their methods or the definition of an 
abnormal cVEMP, so their data was omitted.
Absent cVEMPs at 500 Hz TB are more common in MD (12.5-37%)  than in VM (0-
6%); (Baier & Dieterich, 2009; Taylor et al., 2012). Thresholds were significantly higher for 
the affected ear of patients with MD than for patients with VM (Taylor et al., 2012).
Latencies were not significantly different between patients with MD and VM (Baier & 
Dieterich, 2009; Zuniga et al., 2012; Bremova et al., 2016), but there was a trend for patients 
with VM to have shorter p13 latencies in one study (Bremova et al., 2016).
P13-n23 amplitudes were significantly different between MD and VM for cVEMPs in 
one study (Taylor et al., 2012), but were not significantly different in other studies (Baier & 
Dieterich, 2009; Zuniga et al., 2012; Bremova et al., 2016). Baier & Dieterich (2009)
reported a much lower sensitivity of 69% and specificity of 32% for cVEMP amplitudes, 
indicating that cVEMP amplitudes do not separate MD from VM.
Bremova and colleagues (2016) reported that p13-n23 amplitudes could separate MD 
and VM with 83% sensitivity and 80% specificity, despite being not significantly different. 
However, this appears to be an error as the mean amplitudes for MD and VM were within 
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one standard deviation of each other, indicating a large degree of overlap. Additionally the 
mean amplitude of the MD group was also above the cut-off value and it is highly unlikely 
that 80% of patients were below the mean.
Taylor and colleagues (2012) found the 0.5/1 kHz frequency amplitude ratio (FAR); 
(<-20.4%) separated patients with MD and VM with 35% sensitivity and 90% specificity. 
Murofushi, Ozeki, Inoue, and Sakata (2009) also compared the cVEMP 0.5/1 kHz FAR 
between patients with MD and VM but their definition of VM did not meet the inclusion 
criteria.
Taylor and colleagues (2012) found that the inter-aural asymmetry ratio (>29.2%) 
could separate patients with definite unilateral MD from patients with definite VM with 45% 
sensitivity and 85% specificity. Conversely Martin-Sanz and colleagues (2014) found a 
higher rate of inter-aural asymmetry in patients with VM than in patients with MD. This is 
likely because Martin-Sanz and colleagues (2014) performed testing before diagnosis, and 
bilateral MD, probable, and possible diagnoses were included. However it suggests that 
cVEMP inter-aural asymmetry may not be useful in the early stages of MD and VM.
Overall these findings support some ability of cVEMP asymmetry ratios and FAR 
may be useful in separating patients with MD and VM. However there are not currently 
enough studies to support this.
3.9 Ocular Vestibular Evoked Myogenic Potentials (oVEMP)
The oVEMP is a response from the inferior oblique muscle of the eyes caused by loud 
sounds, vibration, or tap stimuli. The oVEMP is believed to reflect the VOR, and its origin is 
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believed to be from the utricle (for a review see Rosengren et al., 2010). Three studies used 
oVEMPs in both patients with MD and VM (Taylor et al., 2012; Zuniga et al., 2012; 
Bremova et al., 2016). Zuniga and colleagues (2012) found that the click and 500 Hz TB 
oVEMP latency was longer for patients with MD than VM. However, Bremova and 
colleagues (2016) found that oVEMP latencies did not separate MD and VM.
Zuniga and colleagues (2012) found that, for 500 Hz oVEMPs, patients with MD had 
significantly smaller n10 amplitude than patients with VM and healthy controls. However 
there were no significant differences between groups for bone conducted or tap oVEMP n10 
amplitudes. Bremova and colleagues (2016) found that oVEMP amplitudes did not help to 
differentiate MD and VM.
Despite having oVEMP amplitude and latency data for MD and VM, Taylor and 
colleagues (2012) did not statistically compare these measures between MD and VM. They 
noted that oVEMPs showed a similar trend as cVEMPs in that healthy controls and patients 
with VM had largest oVEMPs at 0.5 and 1 kHz, while patients with MD had largest 
responses at 1 kHz. Taylor and colleagues (2012) were unable to analyse the 0.5/1 kHz 
frequency ratio for oVEMPs due to a large number of absent oVEMPs. Overall there is not 
sufficient evidence that oVEMPs can separate patients with MD and VM, but 500 Hz TB 
oVEMPs may be useful.
3.10 Posturography
Posturography involves measuring posture changes in response to experimentally 
induced balance perturbations. (For a review see Visser, Carpenter, van der Kooij, & Bloem, 
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2008). Two studies used posturography in patients with MD and VM (Neff et al., 2012; Hong 
et al., 2013). Neff and colleagues (2012) found no significant difference in the sensory 
organisation test composite score between patients with VM and MD. Hong and colleagues
(2013) found that patients with VM have a higher rate of abnormalities somatosensory score 
for the sensory organisation test (19%) than patients with MD (0%). However no other 
posturography measure was significantly different.
3.11 Linear Motion Perceptual Threshold (LMPT)
LMPTs are obtained by placing a patient in a seat. The seat then moves for 1 second 
in a linear direction, and the patient makes a judgement of the direction that they moved. One 
study used LMPT (Bremova et al., 2016). Bremova and colleagues (2016) found that patients 
with MD had elevated thresholds for naso-occipital and inter-aural movement relative to 
healthy controls and patients with VM. They also found that patients with VM had elevated 
thresholds for head-vertical movements relative to MD and controls. The sensitivities and 
specificities for separating MD from VM using LMPT were 84% and 70% for inter-aural, 
72% and 83% for naso-occipital and 88% and 63% for head-vertical movements. The study 
groups were not age-matched.
3.12 Extratympanic click Electrocochleography (ECoG)
Extratympanic click ECoG is a technique that involves recording bioelectrical 
responses from the cochlea, via the tympanic membrane or ear canal, in response to loud 
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clicks (for a review see: Wuyts, Van De Heyning, Van Spaendonck, & Molenberghs, 1997). 
One study used extratympanic click ECoG (Martin-Sanz et al., 2014). Martin-Sanz and 
colleagues (2014) found that 43% of patients with MD had abnormal ECoG (SP/AP > 50%), 
compared with 24% of patients with VM. While this is only one study, it indicates that 
extratympanic click ECoG is not particularly useful in separating the two conditions.
3.13 Multivariate Methods
Neff and colleagues (2012) found that moderate/severe headache, caloric (directional 
preponderance), rotatory chair test, and initial PTA results could separate MD, VM, and 
patients with both MD and VM (Area under curve = 0.996-1.00). However they did not 
adequately describe the diagnostic tests or provide cut-off values.
Taylor and colleagues (2012) found that a combination of 0.5/1 kHz TB cVEMP FAR
(< -20.4%), 0.5 kHz TB cVEMP amplitude asymmetry (> 29.2%) and caloric asymmetry 
(>25%) separated MD and VM with 90% sensitivity and 70% specificity. However their 
study only included unilateral MD (and not bilateral), and therefore asymmetry ratios are 
likely to overestimate sensitivity for MD.
It is important to note that, as with cut-off values for individual diagnostic tests, the 
use of combinations of individual diagnostic tests should ideally be set a priori. As all of 
these studies determined the best combination of test for separating MD and VM post-hoc, it 
is likely that these sensitivities and specificities are inflated. Despite this, these findings are 
promising and warrant further research.
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3.14 Summary of Evidence
A table summarising the evidence base is presented below (Table 13). There was a 
moderate level of evidence supporting that caloric testing will correctly diagnose MD in 
approximately 50% of patients, while misdiagnosing approximately 20% of patients with VM 
as MD (54.6% sensitivity and 78.9% specificity). This indicates that the caloric test does 
provide some diagnostic value in the differential diagnosis of MD and VM. However a 
caloric result is insufficient to either confirm, or exclude a diagnosis of MD or VM.
Several other diagnostic tests have been compared between patients with MD and 
VM, and show some potential for assisting the differential diagnosis of the two conditions. 
These tests included VIN, HSN, rotatory chair testing, cVEMP asymmetry, 0.5/1 kHz 
cVEMP FAR, and LMPT. However these diagnostic tests had sensitivity and specificity data 
for only one to three studies and therefore meta-analysis of these tests was not considered to 
be appropriate.
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4.0 Results of the Scoping Review
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4.1 Included Studies
Tests that had greater than 70% sensitivity and specificity in at least one study 
included: caloric, VIN, gadolinium magnetic resonance imaging (MRI), 3-dimensional cone 
beam computed tomography, extraympanic click ECoG, transtympanic click ECoG, 
transtympanic TB ECoG, electrovestibulography (EVestG), cochlear hydrops analysis 
masking procedure (CHAMP), and distortion product otoacoustic emission (DPOAE) phase 
shift. Sixty-five studies meeting the inclusion criteria were identified that used one of the 
above tests (Figure 15). Studies that could not able to be accessed can be found in the 
Appendix.
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Figure 15. PRISMA flowchart for the scoping review.
Records identified from PubMed 
(n= 1686) and Ovid (Embase) 
(n=1496)






Full text articles assessed for 
eligibility (n = 831)
Studies that met the first stage of 
inclusion criteria (n = 184)
Studies with measures that had 
>70% sensitivity/specificity in at 
least one study (n = 65)
Full text articles 
excluded, with reasons 
(n = 647)
321 = not relevant 
study design
165 = not relevant 
outcome measures
147 = not relevant 
patient group
14 = could not access
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4.2 Caloric testing
Twenty studies using caloric testing were identified that met the inclusion criteria for 
the scoping review (Jouko, Martti, & Arto, 2003; Yetiser et al., 2004; Furman et al., 2005;
Chen & Young, 2006; Celebisoy et al., 2008; Vitkovic et al., 2008; Baier & Dieterich, 2009; 
Teggi et al., 2009; Neff et al., 2012; Taylor et al., 2012; Hong et al., 2013; Shin et al., 2013; 
Blödow et al., 2014; Martin-Sanz et al., 2014; Kim et al., 2014; Sanyelbhaa Talaat & 
Sanyelbhaa Talaat, 2014; Sharon & Hullar, 2014;  Zhu et al., 2014; Rambold, 2015; Inoue et 
al., 2016).
Ten studies had data comparing MD and VM (Neff et al., 2012; Taylor et al., 2012; 
Hong et al., 2013; Shin et al., 2013; Blödow et al., 2014; Martin-Sanz et al., 2014; Kim et al., 
2014; Sharon & Hullar, 2014; Rambold, 2015; Inoue et al., 2016). However, as these were 
covered in the systematic review, they will not be covered here.
Only two studies compared caloric in patients with MD with a group of healthy 
controls (Yetiser et al., 2004; Sharon & Hullar, 2014). Due to the limited number of studies 
that met the inclusion criteria, not much can be said about the sensitivity and specificity of 
caloric testing for MD based on the studies that met the inclusion criteria (Figure 16). Overall 
these results indicate that there are large variations in the sensitivity of caloric for MD. 
Additionally caloric testing differentiates some patients VM from healthy controls (Figure 
17). As would be expected, specificity was poorer (36 - 79.1%) when MD and VM are 
compared with other vestibular conditions.
A meta-analysis of normative data in the caloric test indicated that the 95% 
CIs for healthy controls was below 25% canal paresis in all identified studies, with an 
average level of 22% (Wuyts & Boniver, 2008). Because of this it can be assumed that 
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caloric testing using 25% as a cut-off value is highly specific (Over 95% of healthy controls 
should have negative caloric results). This is consistent with studies that used caloric testing 
in patients with healthy controls (Figure 16 and 17).
Figure 16. Sensitivity and specificity of caloric testing from studies, when a positive result is 
treated as MD.
Figure 17. Sensitivity and specificity of caloric testing from studies, when a positive result is 
treated as VM.
4.3 Vibration Induced Nystagmus (VIN)
Four studies using VIN met the inclusion criteria for the scoping review (Ohki, 
Murofushi, Nakahara, & Sugasawa, 2003; Neff et al., 2012; Shin et al., 2013; Xie et al., 
2013). Data comparing MD and VM was covered in the systematic review and will not be 
covered here (Neff et al., 2012; Shin et al., 2013). The sensitivity and specificity of VIN is 
presented below (Figure 18). One study identified VIN as having 74% sensitivity and 100% 
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specificity when distinguishing definite MD from healthy controls (Xie et al., 2013). 
However as would be expected the specificity is much lower when compared with other 
vestibular conditions (Ohki et al., 2003; Xie et al., 2013). Interestingly, nystagmus towards 
the affected side appears to be pathognomonic to MD (Ohki et al., 2003; Xie et al., 2013).
Figure 18. Sensitivity and specificity of VIN when a positive result is considered to indicate 
MD.
4.4 Gadolinium MRI
Nine studies were identified that used gadolinium MRI (Fiorino, Pizzini, Beltramello, 
Mattellini, & Barbieri, 2011; Tanigawa et al., 2011; Grieve, Obholzer, Malitz, Gibson, & 
Parker, 2012; Baráth et al., 2014; Hagiwara et al., 2014; Homann et al., 2015; Hornibrook et 
al., 2015; Sepahdari et al., 2015; Ito et al., 2016). Typical MRI cannot clearly visualise the 
inner ear. However gadolinium, a contrast agent,  when injected intratympanically or 
intravenously, enters the inner ear and allows imaging of the perilymph (and therefore the 
endolymph in regions without perilymph); (Nakashima et al., 2007). This enables calculation 
of the relative endolymph and perilymph, and therefore allows visualisation of endolymphatic 
hydrops. (For a review see Naganawa & Nakashima, 2014).
One systematic review was identified on the topic of gadolinium MRI in MD (Ziylan, 
Smeeing, Stegeman, & Thomeer, 2016). However they limited their search to studies with 
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both gadolinium MRI and click ECoG, and therefore did not sufficiently cover the literature 
on gadolinium MRI. 
The sensitivity and specificity of gadolinium MRI for MD is presented below (Figure 
19). Most studies used the grading system that was proposed by Nakashima and colleagues 
(2009). Gadolinium MRI showed 45-64% sensitivity for MD in the vestibule or cochlea, with 
high specificity (Homann et al., 2015; Sepahdari et al., 2015). Sensitivity was higher in 
studies that defined a positive result as hydrops from either the cochlea or vestibule (64-
90%), while maintaining high specificity (Grieve et al., 2012; Baráth et al., 2014; Hornibrook 
et al., 2015; Ito et al., 2016). Several studies found that the vestibule had a higher rate of 
hydrops than the cochlea (Baráth et al., 2014; Homann et al., 2015; Ito et al., 2016). This 
contradicts histological studies that suggest a higher rate of cochlear hydrops (Pender, 2014).
Figure 19. Sensitivity and specificity of gadolinium MRI from studies, when a positive result 
is treated as MD.
One study was identified using gadolinium MRI in patients with MD and VM that 
met the inclusion criteria. Nakada and colleagues (2014) used the Nakashima grading system 
(Nakashima et al., 2009) in patients with VM and vestibular MD (Alford, 1972). While 
vestibular MD is not within the inclusion criteria, it can be treated as a group for comparison 
with VM. They found that significant hydrops in the vestibule was present in the vestibule of 
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100% (7/7) of patients with vestibular MD, whereas only 14% (1/7) patients with VM had 
hydrops in the vestibule.
One study using gadolinium MRI in patients with VM did not meet the inclusion 
criteria for the scoping review due to lack of a control group (Gürkov et al., 2014). However 
it will be summarised here due to its extreme relevance to the topic. Gürkov and colleagues
(2014) used the Nakashima grading system (Nakashima et al., 2009) in patients with VM 
who also had auditory symptoms. They found that gadolinium MRI identified hydrops in
only 21% of patients. This indicates that gadolinium MRI would have relatively high 
specificity for excluding patients with VM.
4.5 Three-Dimensional Cone Beam Computed Tomography (CT)
One study found that three-dimensional cone beam CT of the membranous labyrinth 
could separate patients with definite MD from healthy controls with 84% sensitivity and 
100% specificity (Yamane et al., 2014).
4.6 Electrocochleography (ECoG)
ECoG met the inclusion criteria for the scoping review. ECoG is a technique that 
involves recording bioelectrical responses from the cochlea in response to acoustic stimuli 
(loud clicks or tone bursts [TB]). The responses are recorded by placing an electrode through 
the tympanic membrane and onto the promontory of the cochlea (transtympanic) or in the ear 
canal or on the tympanic membrane (extratympanic); (For a review see Wuyts et al., 1997). 
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In healthy controls, ECoG results in a small summating potential (SP; a direct current 
shift due to cochlea hair cell function) and a large compound action potential (AP; an 
analogue current shift due to primary cochlea afferents of the auditory nerve (Ferraro & 
Durrant, 2006). Gibson, Moffat, and Ramsden (1977) found that 65% of patients with MD 
had enlarged SP in transtympanic click ECoG. Gibson and colleagues (1977) suggested that 
this enlarged SP could be due to displacement of the basilar membrane due to endolymphatic 
hydrops or a change in the ionic composition of endolymph.
One group conducted a general systematic review of ECoG (Lamounier, Gobbo, de 
Souza, de Oliveira, & Bahmad, 2014). They did not produce a meta-analysis, but they 
concluded that TB ECoG was more sensitive than click ECoG. Another group conducted a 
systematic review of click and TB ECoG (Qi & Nunez, 2013). They noted that click ECoG 
had a sensitivity of 53-70% and specificity of 80-90%, and that the combination of click and 
TB measures improved sensitivity to 84-92% and specificity to 85-90%. However this 
systematic review was a poster and was therefore excluded. The studies using ECoG from the 
scoping review were divided into transtympanic click ECoG, transtympanic TB ECoG and 
extratympanic ECoG and are presented below.
4.6.1 Transtympanic click ECoG
Ten studies using transtympanic click ECoG met the (Orchik, Ge, & Shea, 1998; 
Sass, 1998; Ikino & de Almeida, 2006; Gibson, 2009; Baba et al., 2009; Ohashi, Nishino, 
Arai, Hyodo, & Takatsu, 2009; Iseli & Gibson, 2010; Claes, De Valck, Van de Heyning, & 
Wuyts, 2011; de Carvalho Lopes, Munhoz, Santos, Moraes, & Chaves, 2011; Hornibrook et 
al., 2015). Transtympanic click ECoG showed varied sensitivities between studies (Figure 
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20). Various SP/AP ratio cut-off values have been used between different studies, ranging 
from 28-50%. There is a notable trend that transtympanic click ECoG had lower sensitivity in 
studies that used higher cut-off values. Problematically, Gibson (2009) found that 
transtympanic ECoG did not separate MD and controls, when they were matched for hearing 
loss. This indicates that transtympanic click ECoG does not have diagnostic value in MD.
Figure 20. Sensitivity and specificity of transtympanic click ECoG from studies, when a 
positive result is treated as MD.
4.6.2 Transtympanic TB ECoG
There were six studies that met the inclusion criteria using transtympanic TB ECoG
(Sass, 1998; Sass, Densert, Magnusson, & Whitaker, 1998; Gibson, 2009; Iseli & Gibson, 
2010; Claes et al., 2011; Hornibrook et al., 2015). Transtympanic TB ECoG consistently had 
high sensitivity for MD (61.7-91.2%)  and specificity (70.9-91.1%) for separating MD from 
patients with vestibular conditions (Iseli & Gibson, 2010; Claes et al., 2011) and patients with 
hearing loss (Gibson, 2009; Hornibrook et al., 2015); (Figure 21).
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Figure 21. Sensitivity and specificity of transtympanic TB ECoG from studies, when a 
positive result is treated as MD.
Using a 30 Hz tone to increase the size of the SP, Iseli and Gibson (2010) found that 
patients with MD had a reduced increase in SP. A bias ratio (between biased and unbiased SP 
amplitude) of < 1.4 could separate patients with MD from patients with hearing loss or 
vestibular conditions with 85% sensitivity and 80.6% specificity. When this bias measure was 
combined with the 1 kHz TB SP (<-6µV) the tests had 95% sensitivity and 79.1% specificity.
Combining click (>41% SP/AP) and 1 kHz TB ECoG measures (>3.1µV) improved 
sensitivity (82-83%) and specificity (95-100%) for separating patients from MD and patients 
with hearing loss (Sass, 1998; Sass et al., 1998). The addition of click action potential shift 
between rarefaction and condensation to click and TB measures further improved sensitivity 
to 87% while maintaining specificity at 100%. 
Claes and colleagues (2011) found that a combination of 4 kHz TB ECoG and air 
conduction pure-tone audiometry thresholds at 150 Hz, and 8 kHz could separate patients 
with MD from patients with vestibular conditions with 94% sensitivity and 98% specificity. 
While impressive, it is obviously expected that this measure would be much less effective if 
patients were matched for hearing loss.
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4.6.3 Extratympanic ECoG
Eleven studies using extratympanic click ECoG met the inclusion criteria (Chung, 
Cho, Choi, & Hong, 2004; Noguchi, Nishida, Kawashima, Tokano, & Kitamura, 2004;
Hwang, Ho, Hsu, Yang, & Liu, 2008; Satar et al., 2008; Vitkovic et al., 2008; Lee et al., 
2011; Oh et al., 2014; Lamounier et al., 2014; Martin-Sanz et al., 2014; Gerenton et al., 2015; 
Yollu et al., 2016). Data directly comparing MD and VM was covered in the systematic 
review, and will not be covered here (Martin-Sanz et al., 2014). The sensitivity of 
extratympanic click ECoG was highly variable between studies (Figure 22), and this 
heterogeneity did not appear to be consistent with differences in patient groups or cut-off 
values.
Figure 22. Sensitivity and specificity of extratympanic click ECoG from studies, when a 
positive result is treated as MD. Data from Oh and colleagues (2014) was estimated from a 
reciever operating characteristic, at the point which gave 95% specificity.
None of the studies used groups of patients with hearing loss. Noguchi and colleagues
(2004) found that 50% of patients with acute low-tone hearing loss had endolymphatic 
hydrops according to extratympanic click ECoG. They suggested that acute-low-tone hearing 
loss may represent a form of endolymphatic hydrops. It should be noted that only a minority 
of patients with acute low-tone hearing loss progress to MD (Yamasoba, Kikuchi, Sugasawa, 
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Yagi, & Harada, 1994). Because of this it is important to consider that the patients may have 
had positive ECoG results due to their hearing loss rather than endolymphatic hydrops, as 
was indicated for transtympanic click ECoG (Gibson, 2009).
One study found that a combination of the SP/AP ratio with the SP/AP area ratio was 
highly sensitive (90%) and specific (95%) for MD (Ferraro & Tibbils, 1999). However 
another study found no significant difference between MD and health controls using the 
SP/AP area ratio (Oh et al., 2014). Three other studies were identified that used the SP/AP 
area ratio, but were excluded as they did not meet the inclusion criteria (Devaiah, Dawson, 
Ferraro, & Ator, 2003; Al-momani, Ferraro, Gajewski, & Ator, 2009; Baba et al., 2009). 
Two studies meeting the inclusion criteria looked at extratympanic ECoG in VM. 
Vitkovic, Paine, & Rance, (2008) found that 0% of patients with definite VM had positive 
ECoG (SP/AP >50%). However using the same cut-off point, Yollu and colleagues (2016)
found that 38.1% of patients with definite VM had positive ECoGs. With a less conservative 
cut-off value (SP/AP >40%), Yollu and colleagues (2016) found that 71.4% of patients with 
definite VM had positive ECoGs. 
Overall there is a large amount of inconsistency between studies for extratympanic 
ECoG. It is possible that the inconsistencies are due to the higher noise floor of 
extratympanic ECoG.
4.7 Electrovestibulography (EVestG)
Two studies using EVestG met the inclusion criteria (Blakley, Dastgheib, Lithgow, & 
Moussavi, 2014; Dastgheib, Lithgow, Blakely, & Moussavi, 2016). EVestG uses 
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extratympanic ECoG, but tilts or rotations of the body are used as a stimulus, instead of an 
acoustic stimulus (Lithgow, Garrett, & Heibert, 2008; Dastgheib et al., 2016). EVestG using 
a sideways body tilt as the stimulus shows both high sensitivity and specificity (Figure 23). 
The specificity of EVestG using sideways tilt remains high when vestibular patients are 
included (94%). However unclassified responses were common in these patients (33%);
(Dastgheib et al., 2016). All studies using EVestG have been conducted by one research 
group with small sample sizes. It will be important for findings to be replicated by other labs, 
and in larger populations. It will also be important to determine whether hearing loss 
influences the EVestG.
Figure 23. Sensitivity and specificity for sideways body tilt EVestG in included studies, 
when a positive result is treated as MD.
4.8 Cochlear Hydrops Analysis Masking Procedure (CHAMP)
Seven studies using CHAMP met the inclusion criteria (Don, Kwong, & Tanaka, 
2005; De Valck, Claes, Wuyts, & Van de Heyning, 2007; Don, Kwong, & Tanaka, 2007;
Ordóñez-Ordóñez et al., 2009; Kingma & Wit, 2010; Lee et al., 2011; Shang et al., 2012). 
CHAMP involves measurement of auditory brainstem response (ABR) latencies in response 
to clicks and high-pass masking noise. CHAMP is performed by calculating the difference 
between latencies for wave Vs at clicks with high pass noise at 500 Hz and 8 kHz. This 
effectively calculates the time that sound takes to travel from the basal cochlear (8 kHz) to 
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the apical cochlear (500 Hz); (Don et al., 2005). When high pass masking noise is used to 
estimate the speed of sound along the basilar membrane, patients with MD have been shown 
to have higher travelling wave velocity than patients with noise-induced hearing loss 
(Thornton & Farrell, 1991; Donaldson & Ruth, 1996). A physiological explanation is that 
increased stiffness of the basilar membrane, from increased pressure in MD, would result in 
faster movement of sound along the basilar membrane, and therefore shorter latencies (Don et 
al., 2005).
CHAMP is performed by calculating the difference between latency and amplitude 
for wave Vs at 500 Hz TB and clicks. This effectively calculates the time that sound takes to 
travel from the basal cochlear (click) to the apical cochlear (500 TB). The sensitivity and 
specificity of CHAMP latency is presented below (Figure 24). When a standardised criteria is 
used such as <0.3 ms (Don et al., 2005), there is a huge variability of the sensitivity and 
specificity of CHAMP latency measures. Fewer studies have investigated CHAMP amplitude
(Figure 25), but these studies indicate that CHAMP amplitude is highly sensitive and specific 
for separating MD from healthy controls (Don et al., 2007; Shang et al., 2012) and patients 
with vestibular conditions (Lee et al., 2011). Shang and colleagues (2012) found that the 
sensitivity of CHAMP could be improved by combining amplitude and latency measures.
Figure 24. Sensitivity and specificity of CHAMP latency in response to sideways tilts for 
studies, when treating MD as a positive result.
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Figure 25. Sensitivity and specificity of CHAMP amplitude ratio in response to sideways tilts 
for studies, when MD is treated as a positive result.
An issue arises in the fact that all studies compared CHAMP in MD patients with 
significant hearing loss (mean pure tone average: 37.8-47.8 dB HL) to controls with mild to 
no hearing loss (mean pure tone average: < 10-28.3 dB HL). This is not ideal as the wave V 
latency and amplitude are influenced by hearing loss (Stapells & Oates, 1997; Maloff & 
Hood, 2014). An excluded study found that hearing loss had a significant influence on 
CHAMP results (Kim, Jung, Lee, Jung, and Suh, 2015). When they compared CHAMP 
results from patients with MD with controls who were matched for hearing loss they found 
that the means for latency difference were abnormal for both groups when using the <2 ms 
criteria proposed by Kingma and Wit (2010). Unfortunately the study did not contain 
sensitivity and specificity data and was therefore excluded. However the study highlights the 
need for more investigations of the influence of hearing loss on the diagnostic accuracy of 
CHAMP.
Additional problems occur with CHAMP, as 16-50% patients with MD do not have 
CHAMP latency responses (Ordóñez-Ordóñez et al., 2009; De Valck et al., 2007); Shang et 
al., 2012). This is usually due to an absent wave V at 500 Hz (De Valck et al., 2007). For 
instance CHAMP is not recordable in patients with ABR thresholds over 60 dB nHL as the 
wave V is not present in the ABR trace (Shang et al., 2012).
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4.9 Distortion product otoacoustic emissions (DPOAE) phase shift
Two studies using DPOAE phase shift met the inclusion criteria for the scoping
review (Avan, Giraudet, Chauveau, Gilain, & Mom, 2011; Gerenton et al., 2015). DPOAE 
phase in response to a body tilt enabled separation between patients with definite MD, who 
had experienced an attack in the past week, and healthy controls with high sensitivity and 
specificity (Figure 26). However, only 9-28% of patients with MD had abnormal results 
when tested in the interictal period. This indicates that DPOAE phase shift may be a sensitive 
test for acute MD.  However all studies looking at DPOAE phase shift have been conducted 
by one lab. It will be important for these findings to be replicated by other labs.
Figure 26. Sensitivity and specificity of DPOAE phase shift when a positive result is 
considered to indicate MD.
4.10 oVEMP and cVEMP 0.5/1 kHz frequency amplitude ratio (FAR)
The oVEMP and cVEMP 0.5/1 kHz FAR met the inclusion criteria. Three studies 
used cVEMP 0.5/1 kHz FARs (Kim-Lee, Ahn, Kim, & Yoon, 2009; Murofushi et al., 2009;
Taylor et al., 2012); (Figure 27). The specificity of the cVEMP FAR was consistently high 
(90-100%). However the sensitivity was inconsistent between studies, with one study 
showing 93% sensitivity (Kim-Lee et al., 2009), while other studies showed much lower 
sensitivities of 35-56% (Murofushi et al., 2009; Taylor et al., 2012). No clear methodological 
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reason for this discrepancy was identified, although several differences existed between the 
studies, such as stimulus properties and patient selection. Overall these findings support that 
cVEMP 0.5/1 kHz FAR has some diagnostic value for separating MD from healthy controls, 
but further studies are needed to determine its sensitivity for MD.
Figure 27. Sensitivity and specificity of 0.5/1 kHz cVEMP FAR when a positive result is 
considered to indicate MD.
One study found that oVEMP 0.5/1 and 0.5/0.75 kHz FARs separated definite 
unilateral MD from healthy controls with 88.9% sensitivity and 100% specificity (Singh & 
Barman, 2016).
Another study used a combination of cVEMP and oVEMP 0.5/1 kHz FAR and 
cVEMP asymmetry ratio (Maxwell, Jerin, & Gürkov, 2016). They found that the combination 
of the techniques only had had 64% sensitivity and 93% specificity. This suggests that the 
high sensitivities seen in studies using the individual measures (Kim-Lee et al., 2009; Singh 
& Barman, 2016) may not be representative.
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5.0 Discussion
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5.1 Summary of findings from the Systematic Review
Several diagnostic tests have been compared between patients with MD and VM, and 
show some potential for assisting the differential diagnosis of the two conditions. These tests 
included VIN, rotatory chair testing, vHIT, cVEMP asymmetry, 0.5/1 kHz cVEMP FAR, and
LMPT. However these diagnostic tests have only been compared in one or two studies and so 
meta-analysis of these tests was not considered to be appropriate.
There was a moderate level of evidence supporting that caloric testing will correctly
diagnose MD in 55% of patients, while misdiagnosing approximately 21% of patients with 
VM as MD (54.6% sensitivity and 78.9% specificity). This indicates that the caloric test has
some diagnostic value in the differential diagnosis of MD and VM. However a caloric result 
is insufficient to either confirm or exclude a diagnosis of MD or VM.
5.2 Sources of Bias
Notably all of the studies in the systematic review component of this thesis had 
multiple sources of bias. This is consistent with a previous study that identified that most 
diagnostic accuracy studies have at least one methodological flaw (Reid, Lachs, & Feinstein, 
1995). 
One of the primary sources of bias was due to the use of the “probable” and 
“possible” category of diagnosis as a reference test. Diagnostic accuracy studies operate on 
the assumption that the reference test is 100% accurate at diagnosing a condition, and that 
differences between the index and reference test are due to errors in the index test (Van 
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Rijkom & Verdonschot, 1995; Biesheuvel, Irwig, & Bossuyt, 2007). A “probable” or 
“possible” diagnosis is not highly accurate. This creates a problem when using these criteria 
to evaluate diagnostic tests.
Misclassification due to an inappropriate reference test (non-definite diagnosis) 
results in errors. In the diagnostic accuracy paradigm these errors are assumed to be due to 
the index test, resulting in an underestimation of the accuracy of the index test (Biesheuvel et 
al., 2007). Because of this, studies should ideally use pure groups of patients with definite 
MD and VM when evaluating diagnostic tests. Probable and possible diagnoses have value 
also, as these indicate earlier stages of the illness. However the data for these groups should 
be separate from the definite group, so as to minimise misclassification of the reference test.
Lack of blinding was another systemic problem. Only one study used blinding (van 
Tilburg et al., 2016). This is understandable as most studies used the index test to assist 
diagnosis in a clinical setting. However it introduces significant bias as a patient’s diagnosis 
or predicted diagnosis of MD or VM (reference test) may influence how a clinician conducts 
or interprets the index test. Alternatively the results of an index test may influence the 
diagnosis of MD or VM. For instance Bremova and colleagues (2016) excluded patients with 
VM if they had a positive caloric result. While other studies did not state doing this, it is very 
likely that a positive caloric result could lead a clinician to avoid making a diagnosis of VM. 
If either of these biases is present, the results of the index test and reference test are not truly 
independent. Because of this, blinding is an important factor in the quality of diagnostic 
accuracy studies.
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5.3 Summary of findings from the Scoping Review
Several tests with high accuracy for MD were identified. The most well 
established tests with high sensitivity and specificity were gadolinium MRI and 
transtympanic TB ECoG. TB ECoG is believed to detect hydrops of the cochlea, whereas 
gadolinium MRI is believed to be able to detect hydrops of both the cochlea and the 
vestibule. It is therefore understandable that these techniques were found to separate patients 
with MD from patients with hearing loss or other vestibular conditions. Both tests have 
limitations in that they require invasive procedures (transtympanic electrode or transtympanic 
or intravenous injection of gadolinium). Gadolinium MRI is further limited due to the cost of 
obtaining an MRI. MRI is standard procedure for unilateral/asymmetrical hearing loss (to 
exclude vestibular schwannoma). However this cost may not be justifiable in the earlier 
stages of MD where asymmetrical hearing loss may not be present.
The CHAMP and Click ECoG were also identified as sensitive and specific for MD. 
However Click ECoG is influenced by hearing levels, and does not sufficiently separate 
patients with MD from controls when matched for hearing loss (Gibson, 2009). Similar
concerns  have been raised regarding the diagnostic accuracy of CHAMP (Kim et al., 2015). 
No CHAMP studies that met the inclusion criteria for the scoping review matched controls 
for hearing loss. Studies evaluating the sensitivity and specificity of CHAMP under these 
conditions are needed before it is accepted as a diagnostic test for MD.
Other promising techniques for the diagnosis of MD included EVestG, VIN, 0.5/1 
kHz cVEMP/oVEMP FAR, and DPOAE phase shift. However more studies are needed 
before these techniques are established as diagnostic tests for MD. Additionally VIN and the 
0.5/1 kHz cVEMP FAR were compared between patients with MD and VM, and both 
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indicated some degree of separation of the two conditions, supporting that these techniques 
may be valuable in MD diagnostics. These techniques are also all non-invasive.
While DPOAE phase shift could only detect acute MD (within one week of an 
attack), it is still promising. This is because it is a non-invasive procedure and would be able 
to be performed by a trained individual in either private or public settings. If DPOAE phase 
shift is confirmed to be highly sensitive and specific by future studies, it would be possible to 
have patients tested close to an attack, as a specialist would not need to be involved. This 
would make seeing a patient close to attack more viable.
It is important to note that studies using a control group of healthy individuals tend to 
over-estimate diagnostic accuracy (Lijmer et al., 1999; Whiting et al., 2013). This is because 
we do not typically use diagnostic tests on healthy individuals. Studies evaluating diagnostic 
tools for MD ideally need to be evaluated against hearing loss matched individuals and 
patients with other vestibular conditions, as these are the patients that will likely undergo 
these diagnostic tests.
5.4 Inconsistencies between Gadolinium MRI and Histology
One interesting finding was that typically gadolinium MRI identifies hydrops of the 
vestibule more commonly than cochlear hydrops (Fiorino et al., 2011; Homann et al., 2015; 
Ito et al., 2016). This may be contrasted with the recent meta-analysis of  endolymphatic 
hydrops in temporal bones which indicated that saccular and utricular hydrops did not occur 
in the absence of cochlear hydrops (Pender, 2014).
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This may be for several reasons. Firstly the visualisation of the cochlea is more 
difficult with gadolinium MRI. This is particularly true with the apical cochlea (Tanigawa et 
al., 2011), which is responsible for low frequency hearing. This is problematic because the 
apical cochlea is believed to be the most affected part of the cochlea in MD. 
Secondly it may be due to a high rate of false positive results in gadolinium MRI 
(detection of hydrops in the vestibule when there is none). This is also possible as the current 
definition of mild hydrops in the vestibule is >33% which was the mean for normal patients 
(Nakashima et al., 2009). By this definition, approximately 50% of healthy controls are 
expected to have “mild hydrops” of the vestibule.
A third reason is that the criteria for hydrops in histological studies are typically 
qualitative. (For examples of qualitative criteria for endolymphatic hydrops see Rauch, 
Merchant, & Thedinger, 1989 or Lin et al., 2006). A recent temporal bone study constructed 
3D images of temporal bones (Morita et al., 2009). They found that saccular hydrops was 
100% sensitive in temporal bones of patients with MD (more sensitive than cochlear 
hydrops) when using the 95% CI of healthy controls as a cut-off value. It is possible that 
quantitative methods, that are now being utilised (Morita et al., 2009; Nakashima et al., 
2009), are more sensitive for detecting endolymphatic hydrops of the vestibule. If this is true, 
a significant re-evaluation of temporal bone studies for endolymphatic hydrops needs to be 
conducted.
Lastly this may due to processes that occur in active disease, that are not observable in 
temporal bone studies. Gadolinium MRI is the first technique that has enabled in vivo
measurement of vestibular hydrops, and therefore these inconsistencies may be simply due to 
processes that are unique to active disease.
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5.5 Lack of Diagnostic Accuracy Data
For studies systematic review using diagnostic tests with continuous variables (such 
as VEMPs), only a minority of studies (Taylor et al., 2012; Bremova et al., 2016) produced 
cut-off values and data to enable the calculation of sensitivity/specificity. This was also 
encountered in the scoping review. It appeared to be particularly common in studies where a 
significant difference was not found, but also occurred in many studies where findings were 
significantly different. This creates an issue as meta-analyses of diagnostic accuracy cannot 
account for these studies because they do not contain the necessary metrics. This effect would 
be expected to create a source of bias in meta-analyses by making diagnostic tests appear 
more accurate than they actually are. It is therefore important that if a diagnostic test has poor 
sensitivity and specificity in a study, that those aspects are reported. Good options for 
selecting a cut-off value exist in the form of a 95% CI of the control group, or Youden’s J 
statistic (Youden, 1950). Alternatively a receiver operating characteristic could be used.
5.6 Limitations of the Present Study
It should be noted that diagnostic accuracy alone is not sufficient when determining 
the value of a diagnostic test (Fineberg, 1977). The utility of improved accuracy should also 
be considered. The primary purpose of health care is to improve patient outcomes. A test may 
have an impressive diagnostic accuracy, but if it does not improve patient outcomes its value 
is limited (Schünemann et al., 2008). Unfortunately studies of these outcomes, while ideal, 
are often impractical (Bossuyt, Lijmer, & Mol, 2000; Bossuyt, Reitsma, Linnet, & Moons, 
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2012). Because of this, systematic reviews of diagnostic tests typically rely on diagnostic 
accuracy as a surrogate measure of patient outcome (Schünemann et al., 2008). 
The current study may have missed some relevant studies. Only two databases were 
searched, the search was limited to studies in English. Grey literature and unpublished 
literature were also not considered. Additionally the scoping review used diagnostic accuracy 
filters. It is likely that the sensitivity of the systematic and scoping reviews for relevant 
articles was reduced by these factors. One article meeting the criteria for the systematic 
review which was identified but was not available on PubMed or Embase that compared 
VEMPs between patients with MD and patients with VM (Utkur, Durankaya, Idiman, 
Serbetcioglu, & Guneri, 2013). Additionally, one significant paper was identified which was 
missed by the diagnostic accuracy filter, despite being available through PubMed (Pyykkö et 
al., 2013). While the study did not meet the inclusion criteria for the scoping review, it 
appears to be the largest published paper to date looking at gadolinium MRI and its 
sensitivity for MD. While these studies were identified effectively through a grey literature
search (not formally conducted in this study), it highlights the facts that the present study is 
likely to have missed some relevant studies due to methodological limitations.
The quality of studies was not assessed in the scoping review, and no meta-analysis 
was performed. While this limits conclusions from the scoping review, the intent of the 
scoping review was to briefly overview the literature, rather than to be a formal systematic 
review. It is likely that several of the measures identified in the scoping review would benefit 
from formal systematic reviews.
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5.7 Recommendations for Future Research
Gadolinium MRI and transtympanic TB ECoG were identified as highly sensitive and 
specific tests for MD. However neither test has been properly evaluated for the differential 
diagnosis of patients meeting the criteria for MD or VM (with the exception of Nakada and 
colleagues [2014] who compared patients with VM and auditory symptoms with patients with 
vestibular MD). For this reason studies are needed to evaluate the efficacy of these diagnostic 
tests for separating the two conditions. Because they are not proven to separate the two 
conditions yet (particularly because patients with VM may actually have endolymphatic 
hydrops) any use of these techniques for this purpose should be performed cautiously.
The value of diagnostic tests is not limited to diagnosis. Our current understanding of 
the endolymphatic hydrops in patients is primarily based on symptomology and cross-
sectional studies of post mortem histology. Gadolinium MRI and TB ECoG provide 
important tools to be able to monitor endolymphatic hydrops in a living patient, and 
longitudinal studies may give us important insights into the progression of endolymphatic 
hydrops. For instance a recent study has shown a reduction of endolymphatic space following 
acetazolamide treatment (a carbonic anhydrase inhibitor diuretic) in patients with MD. The 
reduction in endolymphatic space was correlated with an improvement of symptoms
(Sepahdari, Vorasubin, Ishiyama, & Ishiyama, 2016).
CHAMP was identified as an accurate test for MD. However future studies should 
attempt to compare CHAMP results between patients with MD and hearing loss matched 
patients. This will be needed to determine whether the test can separate MD from patients 
with patients that are matched for hearing loss.
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To determine whether there is an overlapping pathophysiology between MD and VM, 
post-mortem temporal bone studies of patients with definite VM will be needed to establish
the incidence of endolymphatic hydrops in these patients (and if possible) any association 
with vestibular and auditory symptoms. It is understandable that no studies of this nature 
were identified as VM is a relatively new entity. Because of this it may take some time before 
temporal bones in these patients become available. However studies of this nature will be 
critical to understanding the potential pathophysiological overlap of MD and VM.
5.8 Recommendations for Clinical Practice
The differential diagnosis of MD and VM should continue to be based on the current 
diagnostic criteria (IHS & others, 2013; Lopez-Escamez et al., 2015). There was not 
sufficient evidence supporting any measure that could separate the two conditions adequately. 
A moderate level of evidence supported some diagnostic value of caloric testing with an 
estimated sensitivity of 54.6% and specificity of 78.9%. However caloric testing neither 
confirms neither the presence nor absence of either condition.
Problematically both conditions rely on a diagnosis of exclusion. A reasonable 
approach in the absence of an objective method of differentiation may be to exclude a 
diagnosis of definite MD before attempting a diagnosis of VM. This is supported by the fact 
that systematic reviews show that endolymphatic hydrops occurs in 100% of patients with a 
diagnosis of MD, indicating that a diagnosis of MD is almost certain to have endolymphatic 
hydrops (Foster & Breeze, 2013; Pender, 2014). However, as it is not known with confidence 
whether endolymphatic hydrops occurs in VM, patients meeting the diagnostic criteria for 
both conditions may represent an overlap of the two conditions. 
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While not directly assessed in the systematic or scoping review, the literature (cited in 
the introduction) supports that spontaneous nystagmus is essential in the acute phase of MD 
but not VM. Confirmation of nystagmus can be incredibly difficult due to the transient nature 
of attacks. Our lab has had some success with requesting that patients record their eyes using 
their phones during attacks. This has provided definitive proof of spontaneous nystagmus on 
multiple occasions, and we suggest this as a valuable strategy for both specialists and 
supporting clinicians.
5.9 Concluding statements 
The differential diagnosis of MD and VM continues to be troublesome. There was a 
moderate level of evidence that caloric hypofunction is more common in MD. However 
caloric testing does not reliably confirm or exclude either diagnosis. Temporal bone studies 
are needed to determine whether endolymphatic hydrops occurs in VM. Additionally studies 
are needed to examine whether gadolinium MRI and TB ECoG can differentiate MD from 
VM, as these tests have been demonstrated to be sensitive and specific for MD. Several other 
promising techniques were identified but there was currently insufficient evidence for these.
Further research is needed to establish the value of these tests.
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